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Abstract
Psychological stress is common and contributes to many physical and
mental health problems. Its effects are mediated by a complex neurobiological
system centering in the brain with effectors including autonomic nervous system,
hypothalamic-pituitary-adrenal axis, inflammatory system, and gene expression.
A stressor pushes the human physiological system away from its baseline state
towards a lower utility state. The physiological system may return towards the
original state but may be shifted to a lower utility state. While some physiological
changes induced by stressors may benefit health, chronic stressors usually have
negative effects on health. In contrast to this stressor effect is the system’s
resilience which influences its ability to return to the high utility attractor basin
following a perturbation by increasing the likelihood and/or speed of returning to
the baseline state following a stressor.
Age-related cognitive decline is a major public health issue with few
preventative options. Stress contributes to this cognitive decline, and mindfulness
meditation (MM) is a behavioral intervention that reduces stress and stress
reactivity in many health conditions. A randomized clinical trial was performed to
determine if MM in older adults would improve measures of cognitive function, as
well as psychology and physiology, and to determine what factors might predict
who would improve. 134 at least mildly stressed 50-85 year olds were
randomized to a MM intervention or a wait-list control. Outcome measures
included a broad cognitive function battery with emphasis on attention and
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executive function, self-rated psychological measures of affect and stress, and
physiological measures of stress. Self-rated measures related to negative affect
and stress were all significantly improved as a result of the MM intervention
compared to wait-list control. There were no changes in cognition, salivary
cortisol, and heart rate variability. Potential explanations for the discrepancy
between the beneficial mental health outcomes and lack of impact on cognitive
and physiological outcomes are discussed.
To determine which factors predict MM responsiveness, a responder was
defined by determining if there was a minimum clinically important improvement
in mental health. Predictors included demographic information and selected selfrated baseline measures related to stress and affect. Classification was
performed using decision tree analysis. There were 61 responders and 60 nonresponders. Univariate statistical analysis of the baseline measures
demonstrated significant differences between the responder and non-responders
in several self-rated mental health measures. However, decision tree was unable
to achieve a reliable classification rate better than 65%.
A number of future research directions were suggested by this study
,including to optimize the MM intervention itself, to better select participants who
would benefit from MM, and to improve the outcome measures perhaps by
focusing on decreased reactivity to stressful events. Finally, a less well-defined
but always present future research direction is the development of better models
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and better quantitative analysis approaches to the multivariate but dynamically
limited human empirical data that can be practically collected.
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Chapter 1.
Introduction
The motivation for this research is to be able to better evaluate the effect of a
stress-reducing therapy, mindfulness meditation (MM), in a group of older adults.
The relationship between age-related cognitive changes and stress, and the
remediation of those cognitive changes with a stress-reducing intervention, MM,
is the focus of the research analyses of this dissertation. Chapter 1 provides a
focused background for the research and some details about the data that will be
analyzed in chapters 3 and 4. Chapter 2 consists of a more complete review and
synthesis of the literature concerning a systems approach to stress and
resilience in humans based on a just-published paper by the candidate. Chapters
3 and 4 are papers that utilize specific analytic techniques to analyze data that
were obtained over the last 5 years as outlined in chapter 1. Chapter 5 is a
synthesis and discussion chapter. Some text in the introduction/background and
methods sections in Chapters 3 and 4 are repetitions but are important to ensure
the chapters can stand-alone for journal publication.

Age-related cognitive decline is prevalent with significant cost to society
and very limited preventions. The prevalence of cognitive decline associated
with functional impairment, dementia, is about 14% of Americans over 71 years
old.[1] The cost to the US is around $200 billion.[2] Cognitive impairment without
dementia in those over 71 is even more prevalent, about 22%.[3] Despite the
personal and societal cost and known epidemiological risk factors such as
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hypertension or low education, there are no evidence-based recommendations
for prevention of age-related cognitive decline.[4] There is an urgent need to
develop prevention strategies extending beyond pharmacological and dietary
supplement approaches. Mildly improving cognition and delaying the onset of
dementia by 6 months with a widely available behavioral intervention would
decrease the number of dementia cases by over 100,000 over a 10-year
period.[5]

Older adults are more likely to develop cognitive symptoms from medical
conditions. In addition to slowly progressive cognitive decline, older adults are
much more likely to develop significant but transient cognitive impairments even
to the point of delirium. Overall brain function weakening could be caused by
depression, nutritional defects, oral or anesthetic medications with central
nervous system effects, or simple hospitalization.[6-8] This highlights that older
adults are more susceptible than younger adults to any process that negatively
affects brain function. Developing strategies to decrease the negative impact of
depression and stress contributing to age-related cognitive decline is the
rationale for this research.

Psychological stress is very common and contributes to health problems.
25% of surveyed American adults reported high stress and 50% reported a major
stressful event over the past year according to a 2014 survey.[9] While health
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problems contributed to stress, mundane daily activities also contributed. The top
three were juggling family schedules, hearing about what the government or
politicians are doing, and reading or listening to the news. Stress is caused by
any event with Novelty, Unexpectedness, Threat to ego, or Sense of not being in
control (NUTS).[10] Stress directly costs society through decreased work
productivity and increased sick days. Chronic psychological stress also affects
the underlying pathophysiology or stress-related symptoms contributing to a
broad range of diseases such as cardiovascular health,[11-14] neurologic and
psychiatric diseases such as epilepsy,[15] Parkinson's disease,[16-18] multiple
sclerosis,[19, 20] eating disorders, and addictions.[21] Stress may also worsen
behavioral symptoms such as anger and thus, may symptomatically worsen
disorders such as traumatic brain injury, Post-Traumatic Stress Disorder (PTSD)
and dementia. Therefore, evidence-based approaches that reduce psychological
stress will improve population health.

Psychological stress and reactivity to stress contributes to age-related
cognitive decline. Not only does psychological health affect general health, it
also affects brain health specifically. Chronic psychological stress contributes to
cognitive decline, hippocampal injury, and neurodegenerative diseases either
directly or through stress mediators.[14, 22-27]. The negative effect of
psychological stress on cognitive function may be greater with aging [28-31].
Higher reactivity to negative events produces physiological changes.[32] In fact,
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negative reactions to events are more predictive of emotional well-being than the
event itself.[33] Neuroticism, i.e., elevated stress reactivity associated with
negative emotions, has genetic, neurobiological, and environmental
contributions.[30, 34, 35] High neuroticism contributes to many health
disorders[36] and is linked to increased age-related cognitive change and clinical
Alzheimer disease (AD) in longitudinal studies (although the neuropathology of
this cognitive change or clinical dementia syndrome is not related to amyloid
deposition).[37-39] The cognitive deficits related to proneness to distress are not
specific and most consistently include frontal-executive function and perceptual
speed,[37, 39] similar to cognitive changes associated with affective disorders
such as PTSD and depression.[40, 41] Neuroticism with its negative effects on
cognition is a modifiable risk factor[42] with a potentially large impact on
population health.[43]

Resilience to stress can be protective and can be learned. While high
reactivity to stress can be detrimental to one’s health, resilience to stressors can
be protective. Resilience is the ability an individual’s physiology and psychology
to avoid a diseased/disordered state and/or to return to a baseline state more
quickly following a stressor. Resilience has been used quantitatively in systems
science for decades.[44] However, the adaptive neuroplastic responses
underlying human resilience are just beginning to be understood from the
neurobiology perspective.[45] Depression and stress produce increases in
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amygdala reactivity and size and decreases in hippocampal and frontal cortex
size; resilience to stress might be a marker for neuroplasticity associated with
interventions such as meditation training.[41, 46] Individuals respond differently
to similar negative stressors. Resilience to psychological stress is associated
with no prior history of depression, male gender, lower neuroticism, and high selfesteem and results in decreased incidence of significant psychopathology, such
as PTSD or major depression, when exposed to a stressor.[47-50] Similar
protective characteristics such as self-efficacy, personal mastery, and coping, are
associated with resilience to the stress of dementia caregiving.[51]
Aspects of resilience are also important for minimizing cognitive decline but
this has been underexplored from both the intervention and neurobiology
perspective. Applying the definition of resilience to AD, we could call the brain
insult or stressor AD pathology and the disordered state, dementia. Thus,
resilience to AD pathology can be demonstrated by similar amounts of AD
pathology producing variable cognitive decline. Characteristics of resilience to
the AD pathology could include cognitive reserve,[52] larger brain or
hippocampal size,[53] compensatory ability while performing cognitive tasks,[54]
lesser amounts of co-existing white matter pathology associated with
cerebrovascular pathology,[55, 56] or preservation of neuron numbers, synaptic
markers and axonal geometry.[57] Any intervention that could improve resilience
to stress may favorably influence cognitive decline. While psychophysiological
resilience to laboratory stressors has been widely used, e.g.,[58, 59] the
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experimental reactivity to stressors has not been as widely evaluated using
fMRI.[60-64]
Low doses of a stressor may improve the resilience of the physiological
system[65, 66] Exposure to low doses of stressors reduces stress reactivity,
whether the stressor is exercise[67] or caloric restriction.[68] Psychophysiological
and cortisol responses to stress have been altered by cognitive behavioral
therapy[69] and stress management programs.[70] Decreased prefrontal control
of emotional reactivity is present in depression and can be altered by cognitive
behavioral therapy[40] and meditation (see below).

Mindfulness Meditation (MM) interventions may support cognitive function
in older adults and reduce reactivity to stress and increase resilience. A
behavioral intervention such as meditation that could reduce reactivity to stress
and increase resilience in older adults may improve cognitive decline and thus
reduce overall health costs and burden in the US. Mind-body medicine, such as
meditation and yoga, is the most commonly used type of complementary and
alternative medicine treatment[71] and it attempts to modify individuals’ stress
responses.[72, 73] A recent NIH survey shows that more than 20 million U.S.
adults practice meditation for health. While meditation practices have different
areas of emphasis,[74] MM shows promise in many health conditions. MM is
popular and teaches skills applicable to everyday life situations.[74] A key facet
of MM is attending to the present moment in a non-judgmental way. MM
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intervention has already been formally studied and applied in a variety of clinical
conditions including PTSD, depression, pain, and stress.[75-85]

Meditation decreases negative affect and increases positive affect and
resilience. MM is an acceptable and evidence-based treatment for stress and
depression.[86, 87] Mindfulness has several components.[88, 89] The nonjudgmental component or not reacting overly emotionally to external or internal
events is an important aspect of MM training and is directly related to negative
affect. We have found this non-judgmental component to differ in those with
chronic stress, i.e., veterans with compared to veterans without PTSD,[90] and
older adults who are dementia caregivers compared to age-matched noncaregivers.[30] Positive affect, which is not simply the opposite of negative affect,
may be also improved by meditation.[46, 91, 92] Meditation also decreases
reactivity to computer game stressors,[93] Trier Social Stress Test,[94, 95] and a
film stressor[96] in younger adults.

Meditation is associated with improved cognitive function. Most cognitive
and neuroimaging meditation studies have been uncontrolled or cross-sectional
(comparing experienced to beginner meditators or non-meditators).[97] The
cognitive outcome studies with younger adults and RCTs are limited.[98-105]
Regardless, attention and executive function improvement has been suggested.
A recent systematic review of meditation effects on age-related cognitive decline

8
in older adults[106] found only 6 studies including an earlier study of the
candidate’s, a dementia caregiver study.[107] The improvements on clinical
neuropsychological tests observed in these studies were usually in the frontalexecutive function domain, such as the Stroop task where participants report the
color in which a color-word is written and not simply read the color-word (“blue”
written in red ink should be reported as “red” and not “blue”) [108] and Trails
where participants alternate connecting by pencil sequential letters and numbers
but alternating them (A – 1 – B – 2 – C – 3 …). Meditation likely produces its
cognitive benefits through two mechanisms: 1) improving cognition by decreasing
levels of stress and/or stress reactivity or 2) improving attention through attention
training. (These two mechanisms are not mutually exclusive.) While meditation
holds promise for improving cognitive function more research is needed. We will
focus on meditation reducing stress and improving resilience for improving
cognition in older adults.

Meditation has produced changes in neuroimaging: structural and
functional MRI in younger adults. As noted above with cognitive function, most
meditation structural neuroimaging research consists of cross-sectional or
uncontrolled pre- and post-meditation training comparisons.[109] As with
structural imaging, few RCTs evaluate physiological changes of meditation using
either EEG, event-related potentials or fMRI.[110-112]
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Who benefits from meditation? Despite reported improvements following
meditation interventions, there has been little research into who benefits from
meditation. Given the complexity of the stress system including its interaction
with much of human physiology, it would be helpful to know what factors might
predict clinically significant improvements from meditation since it likely that
some people benefit significantly while others may not benefit at all. At least
some measures of affect impact on response to meditation treatment. People
with panic disorder receiving mindfulness-based cognitive therapy demonstrated
greater improvements in their panic disorder symptoms if they were less
depressed at baseline based on Hamilton Depression Rating Scale. [113] Since
regression to the mean is one confound when determining responsiveness to
treatment, in part explaining some reported placebo effects[114], the fact that the
less depressed people responding more suggests an alternative explanation.

Summary of background and rationale for research. There is evidence that
excessive stress causes cognitive and brain changes and that meditation
practice can reduce levels of stress. There is less evidence that meditation
reduces physiological stress reactivity and very limited evidence that meditation
may improve cognitive function in older adults. It is not known whether the
cognitive function of older adults can be improved with meditation and this is of
very high significance, even if the improvement is only moderate. It is also not
known how reactivity to stress contributes to cognitive change. Understanding

10
how stress contributes to cognitive change and how decreased stress might
improve cognition would be of high significance to guide strategies that maximize
cognitive health in aging. From a Systems Science perspective, there are many
interacting variables measured over time with unclear relationships. It is
important to utilize analysis methodologies that can capture as much of the
dynamic aspects of the data as possible.

Data collection for this dissertation was done under the direction of the candidate
while he was enrolled in the Portland State University Systems Science PhD
program. Two research assistants working directly under the candidate’s
supervision collected the data and another research assistant provided the MM
training intervention. There was no external funding for this particular research
project although the candidate’s NIH K24 award for career development provided
some salary support for the candidate and 50% salary support for a single
research assistant.

METHODOLOGY
Participants consisted of generally healthy adults 50-75 years of age who
reported at least mild stress. Further inclusion and exclusion criteria as well as
recruitment information are provided in chapter 3.
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Figure 1.1. Schematic of participant visits and study flow

There were three testing visits (Figure 1.1), each 2 months apart, and
participants received a 6-week mindfulness meditation (MM) intervention either
between Visits 1 and 2 or between Visits 2 and 3. Participants who received the
intervention directly after Visit 1 were encouraged to continue meditating
between Visits 2 and 3, and participants who received the intervention post-Visit
2 served as a wait-list control. The outcome measures include: 1) self-rated
measures of stress and affect; 2) measures of cognitive function, and; 3)
physiological markers of stress. Further information regarding the rationale and
the specific measures are provided in chapters 3 and 4. Several self-rated
stress/affect measures and a single cognitive function measure were obtained at
each visit using ecological momentary assessment (EMA) that made
assessments using a smartphone at four time points over a 24-hour period
excluding sleep times at the time of each visit while the participants were in their
usual environment.
Intervention
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The MM intervention was administered in six, one-on-one sessions occurring
weekly either between visit 1 and visit 2, or between visit 2 and visit 3 (wait-list
control). The intervention also involved recommended daily home-practice. An
unblinded RA delivered the training sessions but the assessments were
performed by blinded RAs. Having only a wait-list control implies that some
benefit of the MM compared to wait-list may be related to placebo effects [115]
but this study was done with limited funding. Below is a brief description of the
MM intervention and wait-list control condition. Participants who were
randomized to the wait-list arm between visit 1 and visit 2 received the MM
intervention after the wait-list period (between visit 2 and visit 3). Adherence for
the MM intervention was assessed using a study iPod.[116]. All participants met
weekly with the unblinded RA during the active 2-month intervention block and at
the halfway point in the other 2-month block to help minimize drop-outs.

Assessments (Table 1.1)
Outcome assessments were done at each visit. More details are given in Chapter
3.

Table 1.1. Assessments at the three visits
Assessments

Visit 1

Visit 2

Visit 3

(baseline)

(2

(4

months) months)
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Cognitive assessments

X

X

X

Other physiological measures (EEG, ECG,

X

X

X

X

X

X

X

X

X

X

X

bp, respiration rate, cortisol)
Questionnaires: e.g., stress, neuroticism,
mood, fatigue, mindfulness, & resilience
Smartphone ecological momentary
assessment
Adherence (paper log and study iPod)
Expectancy/Credibility

X

Cognitive Assessments were based on prior studies and focused on
frontal/executive function but also included episodic memory, working memory,
and reaction time. At all visits, participants were assessed with self-rated
measures that might interact with or mediate the MM intervention effect, including
stress, neuroticism, mood, fatigue, self-efficacy, sleep quality, mindfulness,
resilience. Physiological assessments include EEG, heart rate and heart rate
variability, and salivary cortisol. Expectancy and Credibility assessments were
performed to determine if expectancy impacted any improvements observed from
the MM intervention.
The next chapter expands on this Introduction to focus on the human stress
system trying to integrate knowledge of the physiology of the stress system with
knowledge from systems science.
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Chapter 2
A systems approach to stress, stressors and resilience in hhumans
Published in Behavioural Brain Research 2015, 282:144-154, authors B.S. Oken,
I. Chamine, and W. Wakeland

Abstract:
The paper focuses on the biology of stress and resilience and their biomarkers in
humans from the system science perspective. A stressor pushes the
physiological system away from its baseline state towards a lower utility state.
The physiological system may return towards the original state in one attractor
basin but may be shifted to a state in another, lower utility attractor basin. While
some physiological changes induced by stressors may benefit health, there is
often a chronic wear and tear cost due to implementing changes to enable the
return of the system to its baseline state and maintain itself in the high utility
baseline attractor basin following repeated perturbations. This cost, also called
allostatic load, is the utility reduction associated with both a change in state and
with alterations in the attractor basin that affect system responses following
future perturbations. This added cost can increase the time course of the return
to baseline or the likelihood of moving into a different attractor basin following a
perturbation. Opposite to this is the system’s resilience which influences its ability
to return to the high utility attractor basin following a perturbation by increasing
the likelihood and/or speed of returning to the baseline state following a stressor.
This review paper is a qualitative systematic review; it covers areas most
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relevant for moving the stress and resilience field forward from a more
quantitative and neuroscientific perspective.
Keywords: psychological stress, systems science, allostatic load, resilience
Abbreviations
ACTH: adrenocorticotrophic hormone
ANS: autonomic nervous system
DHEA: dehydroepiandrosterone
DHEAS: dehydroepiandrosterone sulfate
EEG: electroencephalogram
fMRI: functional magnetic resonance imaging
HgbA1c: glycosylated hemoglobin A1c
HPA axis: hypothalamo-pituitary-adrenal axis
HRV: heart rate variability
PET: positron emission tomography
PTSD: post-traumatic stress disorder
SSRI: selective serotonin reuptake inhibitor
1. Introduction
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Psychological stress is common in our society. A recent survey indicated that
25% of Americans reported high stress and 50% identified a major stressful
event during the previous year [9]. Chronic psychological stress increases risk of
health problems and contributes to cardiovascular problems [11, 117], neurologic
and psychiatric diseases such as epilepsy [118], Parkinson's disease [17],
multiple sclerosis [19], eating disorders, addictions [21], post-traumatic stress
disorder (PTSD), and sleep difficulties. Therefore, it is important to develop
evidence-based methods that minimize stress impact. A fuller understanding of
stress physiology and psychology can be achieved by approaching this topic
from different angles. This work offers a review of stress physiology and
psychology from a systems science perspective.

Systems science is a methodology used to understand complex systems from
organizational, structural, and dynamic perspectives.[119] From a systems
science viewpoint, stress often corresponds to a state away from optimal in a
dynamical system where the optimal location represents a high utility attractor.
An attractor basin in a dynamical system corresponds to the conceptual space of
locations in which the system resides over time. The state of stress results from a
perturbation arising from the internal or external environment (stressor). This
stressor could result in the system returning to the baseline optimal attractor or
moving into a lower utility attractor basin. The attractor basin is the region of
space that shares the same attractor and the whole space may have multiple
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attractors (Figure 2.1).

The attractor in the human system is not a fixed point attractor given the
multidimensional nature and, almost inherent, within-subject temporal variability
of the physiological measures of state. The noise present in the measurement of
the many variables constituting the human system implies the observed human
system is stochastic; thus, the attractors are very difficult to describe. In addition,
given the varying time frames over which the components of the human
physiological system change, the terms state and variable describing more
immediate changes and the terms trait or parameter describing longer time frame
changes represent an artificial separation of the various physiological measures
that have different units and widely distributed half-lives. Whatever the attractor,
even if the system returns to the baseline high utility attractor, there is often some
underlying cost. This cost to the system is a change in the underlying physiology
that may: 1) decrease the rate of return to the high utility attractor or 2) decrease
the likelihood of returning to the optimal attractor following a future stressor
perturbation because the size of the attractor basin is smaller or the attractor has
moved closer to a boundary with a non-optimal attractor basin. The movement of
the dynamical system into a different attractor basin could also be due to a single
severe stressor potentially via a dynamical system catastrophe, for example,
development of PTSD following a single event (Figure 2.2).
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Besides negative effects, the stressor can also induce beneficial changes leaving
the system more resilient to future perturbations, i.e., cause the opposite of 1)
and 2) above. The term resilience includes several conceptual aspects.
Resilience refers to how effectively and quickly the system returns to
baseline.[44] This includes whether the human dynamical system avoids moving
to a lower utility disease state following a stressor.[45] A related term is stability
which refers to how well the system can maintain its current high utility condition
without being pushed away.

Although a stressor may cause a short-term decrease in some measure of utility,
sometimes it results in longer-term utility increase. In the case of humans, this is
related to learning as discussed below. The human dynamical system may
experience some low-stress environmental perturbation that results in a relatively
immediate gain in reward or utility, e.g., obtaining food when hungry or some
longer-term gain in utility, e.g., the brain acquiring a better understanding of the
environment. There is an apparent inverted u-shaped effect of stress on longerterm utility, such that occasional small amounts of stress may improve both
short- and long-term utility but experiencing no stress or large amounts of stress
may have negative long-term effects on the organism. Though the term “human”
will be used, most of this discussion applies to other animals and to systems in
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general.

2. The human physiologic system: brain structure and network (Figure
2.3)
A human is a dynamical system composed of subsystems that help maximize
utility of the organism. Utility may be defined: 1) from a purely biological
perspective such as immediate reproductive success or obtaining food, or 2)
from a more complex, perhaps hedonic or longer-term perspective such as
longer-term reproductive success, obtaining more resources, gaining group
support or enjoying an amusement park ride. Longer-term utility could extend
beyond the lifespan, e.g., survival of the related social unit or the entire species
(see section 9 for more information about utility). The organism is maintained by
many critical systems and subsystems, such as cardiovascular and renal, but this
paper focuses on the brain dynamical system and its communication links with
the body via autonomic nervous system (ANS), hypothalamo-pituitary-adrenal
(HPA) axis and neuroimmune system. The limbic system is involved in
psychological aspects of stress, including neocortex activation by emotional
states and memories of events associated with emotional valences. Older and
more caudal brain parts including the brainstem and spinal cord are generally not
critical for the following discussion with some exceptions including ANS
components. The sympathetic portion of the ANS involving central
catecholaminergic systems is particularly important for communicating the brain
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perception of stress to the whole body by causing changes such as increased
blood pressure and heart rate. The hypothalamus is an important communication
link secreting neurohormones, e.g., adrenocorticotrophic hormone (ACTH).
Given this background, the most commonly discussed physiologic responses to a
stressor involve the HPA axis, the locus coeruleus-norepinephrine-sympathetic
nervous system pathway, the parasympathetic system, the immune system, and
gene expression and alterations including epigenetic changes.

The two-way communication between the major effector systems (ANS, HPA,
and immune) and the brain exist in part to ensure the stress-related systems
provide feedback for learning and help avoid over-reactivity. The communication
system between the immune system and the brain constitutes an entire field
itself, psychoneuroimmunology.[120] The immune system - brain communication
is significantly mediated by cytokines. All these two-way communication systems
directly impact the brain via its receptors for norepinephrine, ACTH, cortisol, and
cytokines, with prefrontal cortex, hippocampus, and amygdala being most
prominent.[121] Feedback is often inhibitory and is not perfect. Occasional errors
in this two-way communication system may arise. For example, a major increase
in heart rate in an exercising older adult with atherosclerosis might be
accompanied by an attempt to decrease the heart rate, but this decrease may be
insufficient to prevent a myocardial infarction and even a sudden death.[122]
Additionally, the awareness of stress may itself be a stressor; however, this type
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of stress is distinct from experiencing external environmental stressors. Stress
awareness may be commonly related to the “recall” or association of particular
environmental inputs with prior stress.

3. Stressor
A stressor is an environmental event that significantly perturbs the entire human
dynamical system away from the optimal attractor resulting in a state of lower
utility. The stressor may move the physiological system to a different attractor
basin, move the system state closer to the edge between its current attractor
basin and another attractor basin of the physiological system (“precariousness”),
or slow the rate at which the system returns to the optimal attractor. The
movement of the system is not dependent solely on objective measures of the
stressor but also on the individuals’ traits of distress proneness and their
perceptions of the stressor. If the perturbation is perceived to impact an organism
negatively or associated with obvious threats (hunger/visualization of aggressor),
there is an immediate effect to reduce the likelihood of a negative stressor
impact. For example, seeing a bear with her cub while hiking will generate
physiological changes important for action (elevated heart rate and blood
pressure) and increased attention to environmental stimuli, thus improving
encoding of the situation for future recollection. These perturbations increase
likelihood of survival over the short-term but if maintained long-term may have
deleterious effects. For example, a transient increase in blood pressure is
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tolerable and may be helpful, but a chronic increase in blood pressure is not high
utility. Stress doses that are not high enough to cause significant health problems
such as disease or death from a state change may produce higher average utility
within the basin by altering the shape of the basin or by moving to a different,
higher utility basin. In an athletics example, both short-term stress at an Olympic
competition and longer-term stress from high effort athletic activity over a training
period may improve athletic performance. However, excessive or repeated
perturbations may have a cost to the underlying system that outweighs the
benefit.

Stressors may include external environment perturbations such as extreme heat
or icy roads while driving. Stressors may also include internal environment
perturbations such as infections or elevated glucose. Stressors may be
predominantly psychological and mediated by brain perception and future
expectancy. Stressors are not necessarily physical changes in the environment
but may involve loss of a significant relationship, financial stress, negative
neighborhood characteristics, or social threats including discrimination [123-126].

For most of this discussion, the stressor referring to perturbations under tight
physiological control will be omitted. Information signals from these perturbations
such as alterations in serum sodium do not need to reach the brain level to be
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regulated. Homeostasis refers to the dynamic control of these state variables
maintained within a narrow window for humans to successfully function. The
dynamical system representing the whole person is regularly exposed to more
heterogeneous stressors than serum sodium changes, including potential
stressors that are anticipated. Allostasis has been used to describe “actively
maintaining homeostasis” [27], but the practicality of this distinction from
homeostasis is uncertain [127].

Some stressors represent state perturbations to which the person may respond
without any obvious long-term negative ramifications. Some stressors, in part
related to their chronicity, may have negative long-term ramifications. The
perturbation may induce changes in several systems. For example, as time
passes from the previous meal, a human’s stomach is growling and blood sugar
is getting lower; the brain senses hunger and mobilizes to address the
perturbation stressor. Part of the response to a stressor will be mediated directly
by the internal environment without requiring any mediation by the brain, e.g.,
hunger causing the release of hormones to break down glycogen. Part of the
response is directly mediated by the brain responsible for planning how to
interact with the external environment, e.g., walking into the kitchen to get food.
The perturbation may induce changes in physiological parameters, e.g., DNA
transcription or epigenetic modifications to alter neurotransmitter receptor
sensitivity. Responding to these stress perturbations may induce some cost to
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the system. This cost may involve the movement of the system into another
basin of attraction or an increase in the probability that the system will move into
another basin following future perturbations.

Though the stressor has some objective qualities, it can be difficult to quantify
because physiological stress effects are highly dependent on the subjective
perception. Quantifying an individual’s stressors has been attempted [128]. Some
examples of stressors include events that have novelty, unpredictability, (any
information-rich input beyond the brain processing ability), threat to one's ego, or
sense of loss of control (NUTS) [129]. Short-term laboratory experimental
stressors are related to these NUTS concepts including the Trier Social Stress
Test, [130], the Montreal Imaging Stress Task [131], titrated Stroop color-word
interference task [132], physical (e.g., putting a hand in ice water) [133], or
perceptual stressors (e.g., the disturbing pictures of the International Affective
Picture Scale [134]). Stress responses can also be conditioned [135] allowing for
comparison between humans and other animals. It is more challenging to study
long-term stressors experimentally but occasional misfortunes such as wars and
other disasters have generated informative epidemiological data, e.g., the World
Trade Center disaster. Stressors may involve awareness of a stressor, even if it
is erroneous, e.g., misperception of an environmental change. Relevant
examples include erroneous stress associations with ordinary loud sounds that
have developed from explosion-related PTSD or a pheochromocytoma producing
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a surge of catecholamines perceived as a stress state because of diaphoresis
and a fast heart rate.

In general, frequent perturbations into a stressed state away from the high utility
attractor have a cost to the system. The cost of going to the refrigerator when
feeling hungry is low. However, a related perturbation, the blood sugar increase
and the need to secrete insulin due to overeating high-sugar items may
eventually cause long-term negative effects. If repeated enough, it may diminish
the human’s ability to stay in a positive functional attractor, and the lack of
responsiveness to insulin at the cellular level (i.e., insulin resistance) may cause
adult type 2 diabetes. This common stress-related change has resulted in a
common diabetes measure, glycosylated hemoglobin HgbA1c, frequently used
as a chronic stress biomarker. In humans, allostatic load is the cost to the system
due to repeatedly returning to baseline, i.e., the costs of executing the
physiological changes and the potential costs of making the changes in
architecture of the basins of attraction (their size, depth, etc.) following a stressor
as well as the eventual impacts of the architecture change. Allostasis has been
used to describe the dynamical control over these variable perturbations for
maintaining a functional state. Though there is some controversy over whether
allostasis is truly different from homeostasis [127], the term allostatic load has
been used as a conceptual measure of the physiological cost due to chronic
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stressors [136] and be will be used in this paper. Attempts to define a metric of
allostatic load for experimental use are discussed below.

4. Measurement of stress
The term stress describes a state of physiologic and behavioral responses to a
stressor with the brain being the critical interpreter of what is stressful. Though
inconsistently used, the stressed state in humans for the purposes of this
discussion is linked to dynamical physiological change. The stressed state also
involves the conscious and unconscious stressor interpretation by the brain
including the conscious perception of the stressors and the perception of the
physiologic response generated by the stressor [137-139]. Stressors result in
changes in state variables and parameters and have been measured using
various biomarkers.

There are many objective ways to measure human stress responses other than
commonly used self-rated scales. As previously noted, physiologic responses to
stress include activation of the HPA axis, activation of the locus coeruleusnorepinephrine-sympathetic nervous system pathway, the parasympathetic
system, immune system, and genes [137, 139-143]. Importantly, the timing of
these changes is variable. When measured as state variables, they may or may
not shed light on the dynamical nature of the physiologic system, resilience, or
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allostatic load. Dynamical aspects of stress and resilience may be estimated with
repeated measurements over longer periods during daily routines or following a
known experimental stressor.

4.1. Peripheral biomarkers
Each biological assessment has a sampling time window. For example, a
peripheral blood draw to assess cortisol reflects cumulative changes over
minutes, cortisol overnight urine collection measure reflects cumulative changes
over hours, and a hair sample may reflect cumulative changes over months.

HPA axis activity biomarkers include glucocorticoids: free cortisol (or
corticosterone in experimental animals), ACTH, and corticotropin releasing
hormone [144, 145]. In addition to acute stressor-induced changes in these
biomarkers, there are alterations in diurnal fluctuations with chronic stress, e.g.,
in cortisol awakening response [85, 146]. Dehydroepiandrosterone (DHEA) and
its sulfate (DHEAS) act to counter-regulate cortisol [147]. DHEA is used as a
stress marker by itself [148] or as a ratio to cortisol and has been affected by
depression [149]. Mineralocorticoids may also be stress biomarkers [150].

Several autonomic activity measures are associated with acute or chronic stress
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including blood pressure, electrodermal response, skin temperature, respiratory
rate, heart rate and heart rate variability (HRV) [151]. A variety of HRV measures
in the time and frequency domains have been evaluated [152, 153]. While HRV
may look at dynamical changes over long periods, e.g., 24 hours or more, longerterm HRV requires more sophisticated data processing to correct for exercise
and unrelated to stress activities modifying the heart rate.

Many measures correlated with stress have been treated as relatively static
measures. There are alterations in immunologic function including cytokines;
gene and epigenetic modifications involving telomere changes; and metabolic
activity fluctuations resulting in generation of reactive oxygen and nitrogen
species damaging to cellular structures [137, 141, 143, 154-156] .

There are other biomarkers not directly related to the currently discussed
physiological stress pathways. To assess stress responses researchers have
used measures of muscle activity e.g., using electromyographic activity for
biofeedback in treatment of muscle contraction and other types of headaches.
Biofeedback has been used on many physiological measures with only few
(peripheral temperature and electrodermal activity) being closely related to ANS
activation [157]. Additionally, as many have casually observed, stress alters
voice characteristics [158] and posture in a chair [159]. Other biomarkers are

29
listed below under allostatic load.

4.2. Brain changes
4.2.1. Cognition
Cognitive function including memory is significantly altered by stress in humans
and non-human animals [117, 160, 161]. Cognitive decline associated with
stress (and the closely related construct depression) may affect speed, attention,
and executive function [117, 162]. Prefrontal cortical dysfunction is particularly
impacted by stress [163]. This pathological relationship becomes more evident
with age [28], and highly stressed elders such as dementia caregivers may be
particularly at risk [155].

4.2.2. Structural brain changes
Stress-related states such as PTSD and fear conditioning are linked to
decreased hippocampal size, decline in prefrontal cortex, increased size of
portions of the amygdala, and decreased inhibition of the amygdala and related
brain regions by the frontal lobes [161, 163-165]. The brain changes are at least
partially mediated by cortisol with increased cortisol related to smaller
hippocampi [166]. The time course of structural change is much longer than the
half-life of cortisol; cortisol elevation needs to be sustained to cause longer-
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lasting brain changes. Smaller hippocampi are common among people with
PTSD or trauma exposure [167, 168] and they also are linked to increased risk
for PTSD development [169] so the causative relationship is uncertain. Further,
PTSD sufferers are at higher risk of dementia [170] and those with smaller
hippocampi have increased the risk of dementia [171]. Therefore, defining the
causative aspects of these relationships is critical and can affect other important
health concerns. From the perspective of beneficial effects, research shows
increased hippocampal volume and improved verbal declarative memory in
PTSD patients after using a selective serotonin reuptake inhibitor (SSRI)
antidepressant for 9-12 months [172]. This is likely related to SSRI-related
neurogenesis increase [173].

4.2.3. Physiological brain changes: EEG, event-related potential, fMRI
EEG stress-related changes, particularly frontal asymmetries [174, 175], and
alterations in event-related potentials [176] have been noted, but these changes
have not been consistent, in part due to lack of distinction between state and trait
markers and limitations in signal processing [177]. Chronic psychological stress
impairs sleep and the resultant sleep deprivation may impact EEG. PET and
fMRI detect brain activation changes due to experimental stressors [63, 178,
179].
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4.2.4. Genetic changes in brain
There are different functional gene classes that underlie the diverse effects of
glucocorticoids on brain function, e.g., energy metabolism, signal transduction,
neuronal structure, and neurotransmitter catabolism [140]. Stress effects on
telomeres have been mentioned but assessments of human telomeres are
generally performed on peripheral blood limiting their direct brain association.

4.3. Allostatic load
The underlying biological definition of allostatic load is very broad since the
physiological system represents a highly multidimensional state space with many
parameters. Potential examples of underlying load include the cost of gene
transcription, metabolic activity, and alteration in cell receptor sensitivity.
Frequent DNA processing may produce changes in telomere length.

Allostatic load was originally developed as a composite marker of chronic stressrelated disequilibrium generated from a number of physiological measures. The
originally described allostatic load score was a composite of 10 measures
(systolic and diastolic blood pressure; waist-hip ratio; ratio of total cholesterol to
high density lipoproteins; high density lipoprotein cholesterol; glycosylated
hemoglobin; overnight 12-hour urinary cortisol, epinephrine and norepinephrine;
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and DHEA-S [180]. The score obtained by summing the ten measures (0 if
normal, 1 if 75th percentile or worse) was associated with mortality. Related
composite allostatic load measures have been correlated to childhood poverty
[181] and measures of work exhaustion [182]. The latter study added several
measures (tissue necrosis factor-alpha, C-reactive protein, fibrinogen, and Ddimer) and other measures have also been added, e.g., pro-coagulant activity.
Despite the widespread interest in allostatic load, the optimum measure has not
been defined; the measures currently used are based on non-experimental
approaches (e.g., simple availability and a priori rationales). As a result there is
much variety in the definition of a composite measure [183], but there needs to
be improvement in its definition to advance the field of biomarkers for chronic
psychological stress. This could potentially result from better analytic techniques.

Allostatic load measures have highly variable time frames. Some may change
relatively quickly, e.g., fibrinogen, some are integrated over some time period
(e.g., 12-hour urinary cortisol), and some change much more slowly or are
integrated over longer time frames (e.g., waist-hip ratio or HgbA1c). Most
physiological parameters are not only stress indicators but also change with
other biorhythms, e.g., circadian or prandial.
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Another rationale for allostatic load as a composite measure of stress effects is
that different people likely have different subsystems affected by stress. Some
people experiencing high stress develop headaches, while others develop
gastrointestinal or other disorders. The particular organ systems affected by
stress is an interaction between these systems and the brain. The individual
reactions to stress are dependent on an individual’s genes, learning and
environment. Thus, it is likely that different people have different patterns of
alteration in stress-related biomarkers or allostatic load component measures
that may potentially be discerned by better analytic techniques, e.g., structural
equation modeling or machine learning. It may ultimately be important to
understand the individual relationships, but at this state of the research it may be
helpful to have a combined measure.

4.4. Stress and disease
Acute stress may have some metabolic, immunologic and cognitive benefits. For
example, alterations in system properties may produce a higher transient utility,
decrease the likelihood that a stressor will move the state of the system away
from an optimal attractor (robustness), or increase the size of an attractor basin
(see hormesis below). A helpful example is the immune system which learns to
react to foreign substances when exposed to non-virulent ones that do not result
in death. If the immune system is not exposed to sufficient foreign substances,
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the result could be over-reactivity to foreign substances or allergies [184].
However, as stated in the introduction, more often impairments in health and a
broad range of diseases are produced by chronic psychological stress.

Chronic stress may cause cognitive decline, adverse effects in the hippocampus,
and contribute to neurodegenerative diseases either directly or through stress
mediators including allostatic load [24, 25, 27, 117, 185]. The negative effect of
psychological stress on cognitive function may be greater with aging [28-30].
Stressors including anesthesia, drugs, depression may be more likely to result in
a state of impaired cognitive function with increased age. Cognitive reserve, a
measure of how well the brain works [52], may be one aspect of resilience to the
effects of stress on cognition.

5. Dynamics of stress system - time course of stress-induced physiological
changes: state/trait and variables/parameters (Figure 2.4)
Stress can cause a perturbation of state but the associated changes to
physiological measures occur at varying time scales. The time courses of marker
changes in psychology are sometimes grouped into fairly mobile, shorter-term
changes reflecting the person’s current state and longer-term, more stable
changes reflecting traits. Standard measures of psychological stress aspects,
such as anxiety, are often measured by a widely used inventory, e.g. the State-

35
Trait Anxiety Inventory [186]. However, even relatively stable traits, such as the
personality trait neuroticism, often considered stable over a lifespan, can be
malleable thus limiting the clear distinction between state and trait. Systems
science uses terms analogous to state and trait: variables reflecting current state
measures and parameters reflecting more stable attributes of the system. The
change in parameters may decrease the likelihood of the system staying in the
optimal attractor basin in the face of typical environmental fluctuations, but the
distinction from variables is simply the time scale and thus is somewhat artificial.
This section is focused on the varying time courses of physiological makers
which are only moderately correlated with commonly used self-rated markers. All
biomarker measurements, including common physiological measurements (e.g.,
cortisol) and many anatomic and experimental physiological measurements (e.g.,
hippocampal size or neuronal receptor sensitivity) change over time, but the time
courses differ.

The sympathetic branch of the ANS is the quickest to respond. Stress response
can be measured by heart rate, blood pressure, electrodermal activity, or
catecholamine release [187]. Epinephrine and norepinephrine release occur in
seconds. The two-minute half-life of epinephrine highlights the generally short
time course of this response. This ANS response is presumably geared to shortacting flight-or-fight changes such as metabolic needs, blood flow, and nonspecific alerting of the brain [188], with norepinephrine projecting throughout the
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brain contributing to both phasic and tonic alertness [189, 190]. HPA activity has
a slower time course and is activated by threats and negative consequences
even when only anticipated. Cortisol has effects throughout the body and is
impacted by many factors other than stress. Cortisol also directly affects the
brain via cortisol receptors present in the pituitary, cerebellum, hypothalamus
paraventricular nucleus and in neocortex. The cortisol peak onset occurs 15-30
minutes after a stressor [178, 191].

Stressor effects on the immune system have a long-time course, and effects on
learning and DNA have even a longer-time frame and are important for sustained
stress effects. Some personality traits have been linked to specific genotypes,
e.g., single nucleotide polymorphisms. For example, a specific genotype
(5HTTLPR) relevant for stress affects serotonin transport and has been related to
stress reactivity [192] and the personality trait of neuroticism. Particularly relevant
for our discussion involving time courses in human stress are the brain network
changes altering perception of the stressfulness of an environmental stimulus;
this may be related to sudden awareness (consciousness) of the stressor or of
the induced physiological state change. A system that reacts differently if
consciousness is achieved and responds based on conscious perceptions and
concepts, such as the perception of causality, is inherently biased.
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There are different approaches to measure stress and resilience dynamically.
One can measure the magnitude of the change at some time point following a
stressor, e.g., the cortisol increase from baseline to 15 minutes after an
experimental stressor. One can incorporate a more sophisticated temporal
measure estimating the area under the curve or half-life of a biomarker stress
response if enough assessments are available. Another measure is the time it
takes to return to baseline following an experimental stressor, e.g., fMRI changes
2 hours after a stressor [63]. In the event one does not use an experimental
stressor, one can observe response following a significant environmental
stressor, as in epidemiological studies related to war injuries or catastrophes. If
enough measurements over sufficient number of days are available it is possible
to calculate the variability of the physiological system. This variability of the
system relates to stress responses but other variables (e.g. age) enter as well.
For example, aging is associated with increased variability of measures of
performance, and this variability can serve as a marker for insipient dementia
among elders [193].

In general, the slowly changing traits or parameters are potentially harder if not
impossible to measure empirically. Given the variable time frame of the
biomarkers, assessment by many repeated measurements over a prolonged
period may provide a better representation of the dynamical stress system
response to psychological stress than single time-point assessments. This is
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especially true because each biomarker already captures the physiological
system over some cumulative time window. The many physiological
measurements needed over a prolonged time can be obtained over days or
weeks using continuous recording in a lab or repeated assessments using
ecological momentary assessment [194, 195]. Looking at reactivity to an
experimental laboratory stressor may also provide good markers of the dynamic
nature of the physiological system related to stress. Epidemiological studies can
use data acquired following population exposure to a common stressor. Figure
2.4 offers a schematic representation of the conditions related to shorter- and
longer-term stressors and physiological responses. There are many systems
science methodologies that could be used to analyze the multidimensional
nature of stress physiology including system dynamics modeling, agent-based
modeling, network analysis, discrete event analysis, Markov modeling, and
control systems engineering [119].

6. Resilience
As discussed in the introduction, the term resilience has been used in different
ways. Resilience affects how effectively and quickly the system returns to a high
utility attractor basin [44]. Despite the neuroscientific interest in resilience [45,
57], its definitions remain variable. Resilience or robustness is the capacity of the
system to return to a high utility attractor following perturbation, the system’s
ability to avoid shifting to another attractor basin presented in this paper as a
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dysfunctional or diseased condition, or moving more quickly to its optimal
location within its original attractor basin (Figure 2.1). Specific examples of
resilience from a systems perspective include: 1) the distance of a location in one
attractor basin to the boundary of an adjacent basin of inferior utility, i.e., greater
resilience means the attractor is further away from boundaries with low utility
neighboring regions; and 2) the strength of the vector field in the basin, where
resilience might mean more rapid return to the attractor, so a repeat of a state
perturbation before full return will make leaving the basin less likely. From a
biological perspective, resilience may refer simply to the ability of a person to
cope with a significant external stressor or insult. Related terms include: stability
or resistance, indicating the difficulty moving a system away from its baseline
"optimal' region; precariousness suggesting system proximity to some threshold
of moving into another attractor basin, and latitude related to the maximum
amount of change the system undergoes before losing its ability to remain within
its high utility attractor basin. The resilience of a dynamical system to maintain
itself within a functional high utility attractor basin is very important to the longterm health of the system. Resilience is not simply the opposite of allostatic load.
Allostatic load is a measure of physiological system parameters that may impact
resilience but it also has other effects on long-term health or disease risk.

It is known that many human stressors are best remediated by significant
behavior change affecting stressor exposure (e.g., ingesting less glucose if pre-
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diabetic or decreasing work hours in a stressful job if hypertensive); some
stressors in humans are related to the perception of the stressor more than the
stressor itself. For example, someone with PTSD is in a pathological lower utility
attractor that could relate to the brain misperceiving the environment in a way
harmful to the person's health (e.g., a truck backfire causing a veteran to engage
in recollections and emotions associated with war).

Resilience to psychological stress is evident when some people avoid significant
psychopathology, such as PTSD and depression when exposed to a stressor
[45]. In the World Trade Center disaster resilience, measured by a likelihood of
developing PTSD, was related to age (older did better), gender (males did
better), social support (more did better), self-esteem (higher did better) and
lifetime history of depression (worse with a positive history), but was not related
to education [47].

Some amount of stress in the environment may be useful for maximizing the
system's ability to respond to future stressors. Humans living with no stressors
may lose the ability to respond to future stressors. From the brain perspective,
some amount of stress is useful for maximizing learning and maintaining
cognitive function. Systems that learn to cope with some amount of stress may
be less affected by future stressors. Hormesis refers to a biphasic response to a
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stressor, “a process in which exposure to a low dose of an environmental factor
that is damaging at higher doses induces an adaptive beneficial effect on the cell
or organism" [65]. This adaptation could be to environmental stressors such as
cold and exercise [66]. A stressor can cause the system to be non-optimal for a
short time but still result in returning to baseline. While there may be some
allostatic load cost, the stressor may induce changes in system physiological
parameters that strengthen the future ability to return to its greater utility
locations, i.e., increase resilience. This low level of stress exposure occurs in
some clinical treatments, e.g., allergy therapy and exposure therapy in PTSD. In
some sense such exposures to a low-level stressor is a way to exercise the
resilience aspects of the system. In general, repeated external stimuli elicit less
of a physiological response because of habituation that can be measured by
fMRI, event-related potentials or electrodermal response [196, 197]. However, in
some cases repeated external stressors result in the excessive response, as in
PTSD (e.g., hyperarousal to loud noises) and become self-reinforced rather than
extinguished.

This decreased efficiency and ability of the human dynamical physiological
system to stay in or get back to a functionally positive attractor basin is the
negative effect of chronic stress or allostatic load. Changing the parameters of
the human system to bring the system back to the optimal state or high utility
attractor often entails a cost to the basic human constituents but the changes can
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be used to simply indicate previous stress exposure. This could be DNA
modification, receptor sensitivity changes, or changes to blood vessels from high
blood pressure. Another example of changes to the underlying system is aging,
which can make a person more likely to exist in a non-optimal state or attractor
basin. It could be that the attractor basin becomes smaller or less steep. The
change of the state space attractor basin that decreases the system’s ability to
stay in its higher utility states without moving to lower utility states in its current
attractor basin or to a lower average utility attractor basin represents the chronic
stress effect or allostatic load. These changes over time can be defined
mathematically. The suboptimal attractor basins do not become necessarily
larger; rather, the high utility attractors become smaller with shallower sides.
Thus, the time required for return to the baseline state tends to increase.

From a probabilistic perspective, the resilience of the system could be
considered the probability that an environmental perturbation results in returning
to the high utility attractor basin, as opposed to ending up in an attractor basin
with lower utility. The capacity of a system to stay in a high utility attractor basin
could be defined stochastically: the likelihood that following a particular
perturbation the person returns to the high utility attractor basin. The capacity to
stay in this high utility attractor basin is especially relevant when, following a
stressor, the state may be closer to the basin boundary and be more likely to shift
to a non-optimal attractor basin should another stressor manifest. Even without
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changing the specific attractor basin but simply the shape of the basin, resilience
could be defined based on the probabilistically weighted average utility in a single
attractor basin following expected stressors.

PTSD is a useful example of state space and attractors since some of the
physiologic responses may initially have been an adaptive response during
specific time and environment but when they persist in other environments, the
result is moving to a lower utility attractor where the abnormal response is selfreinforcing. A high stress physiological state may be high utility during a war but if
that state persists after returning home it can be lower utility. The transition to
PTSD is not reversed immediately as soon as causes are reversed or disappear.
Reversal might require going all the way back to an earlier state in a system
which induces the possibility for a cusp catastrophe (Figure 2.2).

7. Environment and its perception
In addition to knowing the physiological state of the person, one should also
know the state of their environment because certain physiological measures may
be a reaction to the environment. It must be reiterated that although some
environmental stressors have a direct effect on stress responses, e.g., extreme
cold, stress responses are significantly related to the person’s perception of the
stressor. The perception of the environment (Figure 2.3) is affected by a person's
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prior experiences through attention and memory. Many environmental stressors
are stressful because of the way they are perceived and processed. A person
focused on an important phone call may not realize it’s hailing outside because of
their attention on call. As a result, one may not be worrying about whether the car
was left outside the garage. Attention refers to systems in the brain that allow
some information to be processed more than other information [198]. Memory is
a broad term with many subsystems loosely divided into declarative and nondeclarative memory [199]. Emotional memory has critical brain hubs not relevant
for other types of memory. The amygdala rather than the hippocampus is critical
for registering the emotional valence of an event [200]. Beta-blockers that block
aspects of the ANS can have an impact on emotional memory without any impact
on episodic memory [200, 201]. The memory-induced changes in neural
connectivity that result from gene expression and protein synthesis require hours
to days. A person with a memory of a previous environmental stressor will
perceive the perturbation differently from the person with no prior associations to
it. For example, a physically abused wife might associate the noise of her
husband returning home with the physical abuse that often follows. The sound of
an opening door will have different neural associations to her than her nonabused neighbor.

High reactivity to negative events produces physiological changes [32]. In fact,
negative reactions to events are more predictive of emotional well-being than the
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event itself [33]. Reactivity to stress can be examined though neuroticism, one of
the five factors in the widely used five-factor personality inventory [202].
Neuroticism has genetic, neurobiological, and environmental contributions [30,
34, 35]. High neuroticism contributes to many health disorders [36] and relates to
increased age-related cognitive change and clinical Alzheimer’s disease in
longitudinal studies [37-39]. The cognitive deficits related to distress proneness
are not specific and most consistently included frontal-executive function and
perceptual speed [37, 39], not dissimilar to cognitive changes associated with
affective disorders such as PTSD and depression [40, 41]. Neuroticism with its
negative effects on cognition is a modifiable risk factor [42] with a potentially
large impact on population health [43].

The internal physical components of the human are part of the brain
environment, considered the internal environment in contrast to the external
environment located outside the physical body. The brain has partial awareness
of the internal (interoception) and external (exteroception) environment.
Interoception and exteroception may produce brain and other physiological
changes without awareness, but humans can become aware of their internal
states such as anxiety or stress. Interoception may be taught as awareness and
control over internal organs (e.g., learning to modulate one's blood pressure
through biofeedback or mind-body practices).
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As previously mentioned, the effect of an environmental stressor on health may
be modified by how the brain perceives the environment. This perception can be
altered by higher level concepts beyond attention and memory as highlighted by
the concept of hope. From a health perspective, optimists fare better than
pessimists [203] and those with higher religious involvement and spirituality do
better than those with lower involvement [204]. The beneficial placebo response,
i.e., the improvements in physiological measures or perceptions of health
following administration of a treatment without any direct biological affect, can be
elicited by merely telling someone that a treatment may work (even if there is no
directly active components in the treatment) [115, 205]. It is likely that some
mechanisms of placebo or expectancy effects overlap with some of the
mechanisms underlying perception of stress [206]. The major stress hormone
cortisol can be altered by experimental manipulation of expectancy in placebo
effect studies [207, 208].

8. Stress and resiliency biomarker changes with treatment
There are physiological and genetic markers associated with improved resilience
to stress-induced physiological changes [41, 209, 210], and there are also
psychological tools to increase resilience, or the ability to tolerate stress
perturbations without decreasing utility. Exposure therapy has been used to
reduce the person’s reactivity to stressors, e.g., an allergen or an environmental
stimulus precipitating PTSD symptoms. Mind-body techniques and biofeedback
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provide cognitive strategies to decrease emotionally-activated responses, avoid
unnecessary negative internal associations (i.e. sense of stress) to current
events, and to maximize capacity to return to a positive state attractor following a
stressor.

A key facet of many mind-body therapies is mindfulness, attending to the present
moment in a non-judgmental way. With several ways to measure mindfulness,
the judging and negative appraisal of thoughts, emotions, and behavior factor
may be particularly important for stress management. The mindfulness-nonjudgmental score, i.e., being aware of the environment without attaching an
emotional tag [88], is diminished by the chronic stress in dementia caregivers
and in veterans with post-traumatic stress disorder [30, 211].

Mind-body studies have suggested biomarker changes related to mindfulness or
mindfulness training partially overlap with the allostatic load biomarkers but in the
opposite direction. These include telomerase[212], immune function [213, 214],
cognitive function [214, 215], catecholamines [216], HRV [217], cortisol [214,
218-220], EEG [112], structural MRI [221, 222] and fMRI [223]. Meditation alters
physiological responses to an experimental stressor [93]. However, the preferred
or composite biomarkers relating to benefits of mind-body medicine have not
been identified.
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9. Utility
Utility is essentially the same as success of the organism (e.g., life, procreation
or, in the case of humans, earning money). Long-term health is an important
focus of the utility definition concerning stress-related impact on human health.
While utility is the benefit to the person (or genes), the benefit also depends on
the environment, i.e., the specific calculation of utility varies with the environment
and the time course over which it is calculated. During war, utility is more
immediate, perhaps simply surviving to the next day with a very high discount for
future situations. Therefore, utility of a response to a stressor depends on the
environment and on a person's degree of discounting future events. Thus, the
calculation of utility in different environments will be dependent on the rewards
and penalties in the current environment and on the time duration and differential
weighting used for calculating the utility.

10. Conclusions
This paper has described human stress physiology and psychology from the
systems science perspective. Specifically we focused on environmental
perturbation stressors that produce significant long-term changes in the human
dynamical system. Acute stressors usually do not produce long-term negative
effects although a significantly powerful acute stressor may push the brain
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dynamical system into a new, functional attractor basin with lower utility. In
general, chronic psychological stress produces changes in the system, such as a
slower response to a future stressor or a higher potential for moving to a new
lower utility attractor basin. If a human is exposed to a “tolerable” dose of a
stressor that results in return to the original high utility attractor basin, the
outcome may be improved resilience. From a systems science perspective,
behavioral and physiological measurements attempting to capture the degree of
stress of a system should incorporate the dynamics of the physiological stress
response system as well as some measures of the environmental stressors and
their perception. Understanding stress will require all of the interacting
components from Figure 2.3 to be measured and described, at least partially. In
general, the systems dynamics of stress physiology has much less temporal
empirical data to inform the model than, for example, meteorological data
because of the difficulty acquiring the human data. Nevertheless, analyzing
dynamical data will be important to better understand stress physiology since the
timing and strength of feedback loops likely contributes to disorders of stress and
resilience to stress. In addition to measuring stress responses over time, it may
be useful to repeat administration of experimental stressors to understand selfreinforcing loops. These systems science concepts and better measurement
techniques will lead to better understanding of the stress system that ultimately
can be used to improve the resilience of the human system and thereby improve
long-term health.
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Figure 2.1. Schematic of attractor basins for high and low resilience.
Hypothetical example of space of possible human physiological states with two
attractor basins, one being a healthy higher utility condition and one a lower utility
condition state of PTSD (in this figure, higher utility is downward). The attractor
basins can tolerate movement of the hypothetical person (solid circle) in the
horizontal direction from an external stressor without leaving its basin of
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attraction. However, with sufficient movement from a stressor, one may go from a
higher utility healthy condition basin to a lower utility PTSD basin. The healthy
condition in b has lower resilience than in a, with less stress required to shift it to
the lower utility basin.

Figure 2.2. Schematic of cusp catastrophe for post-traumatic stress disorder. An
example of a cusp catastrophe where the state space of human physiology has a
complex 3-dimensional shape, with no pictorial representation of attractors, and
there may be an abrupt state change. In this example, as stress increases at
higher levels of depression there may be a sudden drop in location to a new
state, PTSD (marked by a dotted line). Here, utility is up rather than down as in
Figure 2.1
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Figure 2.3. Stress system with input, brain, effectors, and moderators
(2.3 Top) The brain’s perception of the emotional valence of an external event as
a stressor is dependent on the current environment and modulated by previous
experiences (memory), current physiological state, traits (e.g., neuroticism), and
genotype. The brain generates outputs to the autonomic nervous systems
(ANS), the hypothalamo-pituitary-adrenal (HPA) axis, the immune system, gene
expression and epigenetics (overall increasing time duration of stress activation
components from left to right. These responses directly affect the body but also
feedback to the brain. Learning includes assessment of risks and rewards and it
can be clinical designed to reduce reactivity, e.g., allergy therapy or mindfulness
meditation. (2.3. Below). Example of self-reinforcing stress response system that
is pathological if in a non-threatening environment. Normally, while stress
activation from a loud non-threatening noise may initially activate a stress
response, response to repeated loud noise will be attenuated through negative
feedback (e.g., habituation). In PTSD emotional memories and the stress
activation itself may contribute to an auto-reinforcing positive feedback loop. As
mentioned in the text and Figure 2.2, this PTSD attractor basin may be entered
secondary to a single severe negative event via a catastrophic dynamical
systems event. This pathological transition is more likely in those with
predispositions, e.g., neurotransmitter alterations such as depression.
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Figure 2.4. Potential state examples based on 3-dimensional stress model
A rough schematic of three dimensions related to stress. Physiological activation
can be low or high and sustained for a short or long period of time. The response
can be to a stressor that is relatively low from an objective or population
perspective or relatively high. Normal function usually goes from relaxation state
(a) to short duration high physiological activation when exposed to a stressor (f).
If the stressor response is too sustained or occurs too frequently, there is some
cost to the system.
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Chapter 3.
Meditation in stressed older adults: effects on stress, affect, cognition, and
physiology.
(edited version submitted to Psychology and Aging, January 2016)

Abstract
Objective: Determine if mindfulness meditation (MM) in older adults will improve
measures of psychology, cognition and physiology impacted by stress.
Methods: 134 at least mildly stressed 50-85 year olds were randomized to a sixweek one-on-one MM intervention along with home practice or to a wait-list
control (ClinicalTrials.gov NCT01386060). Outcome measures assessed at
baseline and two months later at Visit 2 included Positive and Negative Affect
Schedule (PANAS), Center for Epidemiologic Studies Depression (CESD),
Perceived Stress Scale (PSS), Neuroticism-Extraversion-Openness (NEO)
personality traits, SF-36 health-related quality of life, a broad cognitive function
battery with emphasis on attention and executive function, salivary cortisol,
respiratory rate, and heart rate variability.
Results: 128 participants completed the MM study though Visit 2 assessments.
Self-rated measures related to negative affect and stress were all very
significantly improved as a result of the MM intervention (PANAS-negative,
CESD, PSS, and SF-36 health related quality of life (Vitality and Mental Health
Component). There were significant changes in some personality traits especially
Neuroticism. Positive affect were not significantly changed. There were no
changes in cognition, salivary cortisol, and heart rate variability.
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Conclusion. Mental health in the MM intervention group was significantly
improved compared to the wait-list control, with some clinically important
differences in SF-36 Vitality and Mental Health Component scores. These selfrated improvements were not paralleled by improvements in cognitive function or
physiological measures. Potential explanations for this discrepancy in stressrelated outcomes are discussed at length.

Keywords (up to six)
Meditation, stress, cognition, fatigue, mental health, older adults

Abbreviations/acronyms
BP – Blood Pressure
CAR – cortisol awakening response
CERAD – Consortium to Establish a Registry for Alzheimer’s Disease
GDS – Geriatric Depression Scale
GPSE – General Perceived Self-Efficacy
HRV – Heart Rate Variability
LF/HF – Low to high frequency
PTSD – Post traumatic stress disorder
PSS – Perceived Stress Scale
CESD – Center for Epidemiologic Studies Depression
PANAS – Positive and negative affect schedule
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PSQI – Pittsburgh Sleep Quality Inventory
NEO – Neuroticism-Extraversion-Openness
SF-36 – Short form 36-item health related quality of life
FDR – False discovery rate
MM – mindfulness meditation
Resp - Respiration
SDRR – Standard deviation of inter-beat interval
WAIS- Weschler Adult Intelligence Scale
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Currently, age-related cognitive decline stands as a major public health issue,
with high societal costs and few preventative options. The prevalence of
cognitive decline associated with functional impairment, referred to as dementia,
is about 14% of Americans over 71 years old [1] with a resultant high cost to the
US of $200 billion [2]. Cognitive impairment without dementia in those over 71 is
even more prevalent, affecting about 22% of the population [3]. Older adults are
more likely to develop cognitive symptoms from medical conditions. For example,
in addition to slow progressive cognitive decline, older adults are much more
likely to develop significant, transient cognitive impairments, even to the point of
delirium. A weakening of overall brain function could be caused by depression,
nutritional deficits, oral medications with central nervous system effects,
anesthetics, or simple hospitalization [6-8]. This point highlights how older adults
are more susceptible than younger adults to any process that negatively affects
brain function. Despite the personal and societal costs and known
epidemiological risk factors, such as hypertension and low education, there are
no evidence-based recommendations for prevention of age-related cognitive
decline [4]. Mildly improving cognition and delaying the onset of dementia by
even 6 months with a widely available behavioral intervention would decrease
the number of dementia cases by over 100,000 over 10 years [5]. Developing
evidence-based strategies to decrease the negative impact of depression and
stress that contribute to age-related cognitive decline was one goal of this study.
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Psychological stress is one important factor in the general population and
specifically with older adults that can be addressed by behavioral interventions.
Psychological stress is very common and contributes to many physical and
mental health problems. About 25% of surveyed American adults reported high
stress and 50% reported a major stressful event over the past year [9]. Stress is
potentially caused by events with Novelty, Unexpectedness, Threat to ego, or
Sense of not being in control (NUTS) [10]. Chronic psychological stress has
multiple effects on physiological systems [24, 224] and the underlying
pathophysiology of stress-related symptoms, contributing to a broad range of
diseases, such as cardiovascular health [11-14], epilepsy [15], Parkinson's
disease [16-18], multiple sclerosis [19, 20], eating disorders, and addictions [21].
Stress may also worsen behavioral symptoms, such as anger and anxiety, which
symptomatically worsen disorders such as traumatic brain injury, post-traumatic
stress disorder (PTSD), and dementia. Importantly, chronic psychological stress
and excessive reactivity to stressors contributes to age-related cognitive decline,
hippocampal injury, and neurodegenerative diseases either directly or through
stress mediators [14, 22-27] with the effect being even greater with aging [28-31].
Higher reactivity to negative events produces physiological changes [32]. In fact,
negative reactions to events are more predictive of emotional well-being than the
event itself [33]. Elevated stress reactivity associated with negative emotions,
neuroticism, has genetic, neurobiological, and environmental contributions [30,
34, 35]. High neuroticism contributes to many health disorders [36] and is linked
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to increased age-related cognitive change and clinical Alzheimer’s disease in
longitudinal studies (although the neuropathology of this cognitive change or
clinical dementia syndrome is not related to amyloid deposition) [37-39].
Proneness to distress elicits deficits that are not specific and consistently include
frontal-executive function and perceptual speed [37, 39], similar to cognitive
changes associated with affective disorders such as PTSD and depression [40,
41]. Reducing stress reactivity and thus its negative effects on cognition may be
a modifiable risk factor with a potentially large impact on population health [43].

Mindfulness meditation (MM) is a behavioral intervention that shows promise in
being able to reduce stress and stress reactivity in many health conditions. MM is
a popular meditation approach that has been formally studied and applied in a
variety of clinical conditions including PTSD, depression, pain, and stress [7583]. However, the evidence for efficacy has not been definitive across the board
in part related to lack of objective not self-rated markers of improvement [84-86,
225] although there is moderate evidence for the reduction of anxiety, depression
and pain symptoms [86, 87, 225]. Mindfulness meditation has not been well
evaluated in older adults as a behavioral intervention to reduce stress and stress
reactivity and thus, potentially improve cognitive function.

Goals of study
The goal of this study was to further elucidate and better define the benefits of
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MM training in older adults using a broad battery of outcomes related to stress,
physiology, and cognition. This goal was accomplished by examining which
outcomes have greater effect sizes from MM training. In a randomized controlled
trial, mildly stressed older adults were allocated to a six-week one-on-one MM
intervention or a wait list control. We hypothesized that psychological, cognitive
and physiological measures related to stress would improve with the MM
intervention.

METHODS
Participants
Participants consisted of generally healthy adults 50-85 years of age who
reported at least mild levels of stress. The upper age cutoff helped to limit
instances of multiple brain pathologies contributing to age-related cognitive
alterations [55, 226, 227]. Participants were recruited from the Portland, Oregon
metropolitan area.

Following inquiries, participants were informed about the study and eligibility
criteria. If interested, they underwent a 30-minute telephone eligibility screening
for which there was an IRB-approved Waiver of Authorization granted where
health history and demographic data were collected and several questionnaires
were administered. This study was approved by the Oregon Health & Sciences
University Institutional Review Board (IRB) and was registered with
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ClinicalTrials.gov (NCT01386060). Participants provided informed consent during
Visit 1 at the research lab. Exclusion criteria were primarily to screen out an
underlying illness that might limit the benefit of the intervention, confound
outcomes, or increase the likelihood of dropout (Table 3.1).

Table 3.1: Inclusion and exclusion criteria
Inclusion  Age 50-85 years old;
Criteria
 Baseline Perceived Stress Scale (PSS) [228] score ≥ 9;
 Agree to follow the study protocol including randomization
.
Exclusion  Cognitive impairment (significant participant complaints) or a
score of less < 30 on the Modified Telephone Interview for
Criteria
Cognitive Status (TICS-m) [229]
 Significant patient-reported medical/neurologic disease (e.g.,
major organ failure; insulin-dependent diabetes, active cancer,
or alcoholism);


Significant, untreated depression. Significant was defined
based on Geriatric Depression Scale greater than 5 and
interview;



Take medications known to affect CNS function or impact
physiologic measures (e.g., steroids, neuroleptics or regular
narcotic analgesics); stable doses of CNS-active drugs with
less impact (e.g., beta-blockers, SSRI’s, and histamine
blockers) were acceptable; enrolled participants were
encouraged not to change their drug use during the study
period and to inform the investigator if any change was made.



Cannot understand the instructions (e.g., cannot hear or see
study materials or not fluent in English);



Prior experience with meditation classes or other mind-body
classes (e.g., yoga or tai chi) within the last 24 months or more
than 5 minutes daily practice in the last 30 days.
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Randomization and follow up
Following Visit 1, participants were randomized to a six-week one-on-one MM
intervention or a wait list control. All randomizations were performed by nonblinded research personnel using a computerized covariate adaptive
randomization procedure [230] aimed at balancing active and wait- list groups on
age, gender, and baseline Perceived Stress Scale score using a pre-determined
projected median split for the continuous measures. The research assistant who
led the meditation training sessions performed the randomization, and the
research assistants who conducted data-collection visits remained blinded. There
were three assessment visits that were approximately three hours long and two
months apart. Participants in the MM group received a 6-week one-on-one
intervention adapted from MBCT [231] between Visits 1 and 2 but received no
intervention between visit 2 and visit 3. In contrast, participants in the wait list
group received no intervention between visits 1 and 2, but received the 6-week
one-on-one intervention between visits 2 and 3. This primary outcome paper
analyzes only the Visit 1 and Visit 2 data. The outcome measures include: 1)
self-rated measures of stress and affect and 2) biomarkers of stress including
cognitive function, salivary cortisol, blood pressure, respiration rate, heart rate
and heart rate variability (HRV).

Intervention
MM was the active intervention administered in this randomized controlled trial
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(RCT). The intervention was administered in six, one-on-one training sessions
occurring weekly and also involved recommended daily home-practice. As
mentioned above, an unblinded research assistant delivered the training
sessions.
MM: The MM in this study is a standardized and structured one-on-one program
[231] based on MBCT [232, 233]. The MM training objectives were to: 1) help
participants understand their personal reactions to stress, 2) teach those skills to
modify their stress reactions, and 3) promote their desire for self-care and
feelings of competence and mastery. Participants attended 60-90 minute training
sessions once a week for six weeks, and the six trainings all followed a similar
format. The length of the sessions varied to some degree by weekly syllabus
length and by participant characteristics. Most sessions began with a 30-minute
guided meditation, followed by discussion about the participant’s meditation
experience, conversation about establishing a regular home practice,
presentation of new materials, and explanation of home practice. Formal
meditation instruction included a 30-minute Body Scan, 30-minute Sitting
Meditation, 30-minute Sitting with Difficulty Meditation, and 4-minute Breathing
Space. Informal practice of mindful daily activities (e.g., washing dishes, eating)
were taught to generalize mindfulness beyond the formal meditations. A brief 3Step Coping Space meditation was also taught as a quick coping strategy
intended to be used during times of stress in daily living. The research assistant
leading the MM intervention was educated in Buddhist meditation with previous
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experience teaching secular 1-on-1 MM with adults enrolled in other RCTs [234,
235].

Participants were instructed to practice at home 30-45 minutes a day as a goal
but to practice at least some amount every day. The meditation home practice
audio recordings had several possible shorter interval breaking points denoted by
tones to allow flexibility for unpredictable time demands facing stressed adults.
MM sessions will also offer strategies other than meditation for practicing
mindfulness skills to cope with the many stressors that adults typically face.
Wait-list: Participants randomized to the wait-list arm between Visit 1 and Visit 2
received the MM intervention after the wait-list period (i.e., between Visit 2 and
Visit 3). This was done in part to facilitate recruitment and decrease
disappointment following randomization.
Adherence (Compliance) and retention: Attendance at the weekly in-person
sessions was tracked. Adherence to the MM home practice for the MM
intervention was assessed by iMINDr, a software application on a study iPod
Touch (Apple, Inc.) lent to the participants for the duration of the study [116]. All
participants met with the non-blinded RA six times for 90 minutes during the
active 2-month intervention block.

Outcomes
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The outcomes were self-rated questionnaires, cognitive assessments, and
physiological measures.

Self-rated measures (Stress, affect, personality and quality of life
outcomes). At all outcome visits, participants were assessed with self-rated
measures that might be affected by the MM intervention or mediate the MM
intervention effect on the objective measures. Forms were sent to participants
prior to the in-lab assessment visits and were filled out at home, taking less than
one hour to complete.
 Stress: Perceived Stress Scale [228].
 Personality: While neuroticism has been considered a stable trait, changes in
neuroticism are a possible outcome from meditation studies [212]. Neuroticism
was assessed with the shortened version of the NEO [202] that assessed the
other personality traits as well.
 Affect: Positive and negative affect schedule (PANAS) [236] and the Center
for Epidemiologic Studies Depression Scale (CESD) [237]. While the
conventional, standard, 20-question trait version of the PANAS was filled out at
home, the 10-question state-version was filled out in the lab setting [236, 238,
239] in preparation for its use in ecological momentary assessment. The state
question PANAS asks participants “right now I feel …?” in contrast to the
standard version that asks participants “Indicate to what extent you generally feel
this way, that is, how you feel on the average.”
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 Fatigue and quality of life: The SF-36 health-related quality of life was
administered. The outcome measures included the 4-question Vitality (Energy
and Fatigue subscale) [240] that was previously found to be sensitive to yoga in
two studies [241, 242]. Besides the Energy and Fatigue subscale, the Physical
and Mental Health Composite summary scores were calculated using
http://www.sf-36.org/nbscalc/index.shtml [243].
 Self-efficacy: The General Perceived Self-Efficacy (GPSE) Scale [244] was
included because participants have previously reported that their sense of control
was significantly affected by meditation [107, 245, 246].
 Mindfulness: Two factors from the Five Factor Mindfulness Questionnaire [88]
were assessed: the Mindful Attention Awareness Scale and factor 5, mindful nonjudging. The latter was found in prior studies to be significantly different in
chronically stressed populations, i.e., it was different between veterans with and
without PTSD [211] and between dementia caregivers and non-caregivers [30].
 Sleep: The Pittsburgh Sleep Quality Index (PSQI) [247] was administered
because mind-body therapies improve sleep function [248] and may mediate
stress effects on cognition [249].
 Expectancy/Credibility [250, 251] & Teacher Credibility [250, 252] were
administered to determine if expectancy is associated with any improvements
observed from the MM intervention.
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Cognitive assessments were based on prior studies [30, 80, 107] and focused
on attentionally demanding frontal/executive function tasks but also included
assessments of episodic memory and reaction time. The cognitive outcome
measures were: the Stroop Color and Word Test [108, 253]; a flanker attention
test where participants decide whether a central arrow surrounded by flanker
arrows is pointing left or right; the Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) wordlist memory test (Morris et al 1989) that is a
measure of episodic verbal memory where participants are read a series of
words for later recall [254]; letter and category verbal fluency from the multiple
form version of the Controlled Oral Word Associates test [255]; WAIS Letter–
Number Sequence that is a measure of working memory where participants are
read a mixed string of letters and numbers and immediately state the string with
the letters and digits each in their own alphabetic/numerical order [256] and;
simple and choice reaction time [251]. The flanker attention test administered in
the lab was sensitive to MM in a prior study [107] and to caregiving stress [30].
For the flanker task, to respond, participants tap on the left or right side of a
touch screen on a hand-held device. The test has 30 congruent (flankers in same
direction) and 30 incongruent (flankers in opposite direction) trials and lasts 2.5
minutes.

Physiological assessments were conducted at rest in the lab after
participants had been seated for 30 mins and included the following: 1) systolic
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and diastolic blood pressure (average of two obtained in succession using an
automatic digital inflation cuff); 2) respiration rate using light elastic piezoelectric
strap around chest near the diaphragm (Ambu-Sleepmate, Maryland) recorded in
three consecutive 5-minute blocks when participant was listening to auditory
recordings without any task and; 3) electrocardiogram (ECG) for heart rate and
conventional heart rate variability (HRV) frequency analysis measures [257, 258].
Respiration was recorded during three consecutive 5-minute time blocks while
the participants were seated listening to audio without any task. Respiration rate
was calculated in BrainVision. Breaths were labeled semi-automatically using a
voltage trigger to label peak values. HRV measures from a 5-minute recording
were low frequency (LF, 0.04-0.15 Hz) to high frequency (HF, 0.15 – 0.40 Hz)
ratio and standard deviation of the RR interval following methodology as used
previously [153]. Electrodes were placed, amplified using BioSemi amplifiers, and
ECG was processed using Kubios and BrainVision software. We also measured
resting heart rate since previous findings suggested that heart rate is more
sensitive to mild mental stress than the typical HRV frequency analysis measures
[153]. Saliva for cortisol was collected at home and analyzed as previously done
[30, 259] with saliva samples obtained on two days at three time points:
immediately on awakening, 30 minutes later and before bedtime. If participants
followed directions and collected all samples, data was averaged across the two
days. If for any reason a sample was missing, just a single day’s data were used
rather than the average, knowing the single day measure might produce
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significantly worse reliability [260]. Some have suggested more than two days of
sampling per occasion but this study was constrained by budget to two days of
sampling per visit. Thus, the cortisol outcome data for each visit consisted of a
single salivary cortisol measure upon awakening, 30 minutes later, and just prior
to bedtime.

Analysis
All data analyses were done in Stata 14 (StataCorp, College Station TX). Data
were first inspected to ensure there were no outliers and extreme outliers (more
than 4 standard deviations) were deleted. Data were assessed for normality
using Shapiro-Wilk. Data transformations were used in the event of non-normality
(e.g., square root or Box-Cox). Fisher’s exact test was used to compare the rate
of study completion.

The primary analysis for outcome measures was analysis of covariance of Visit 2
outcome data by intervention group with the Visit 1 data as covariate. Age and
years of education were entered as covariates for cognitive outcome measures
given their known relationship and were kept in the model if their p value was
less than 0.10. There are many potential outcome measures. One goal of this
study was to evaluate the MM effect sizes on all the outcome measures and
these are reported as partial eta squared. For multiple comparisons, the type I
rate was controlled for using the false discovery rate (FDR) [261] with an overall
FDR rate of 0.05. Both the unadjusted p values and FDR corrected p values
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using R program p.adjust are provided in the outcomes table but p values
mentioned in the results and discussion text are all corrected values. Pairwise
Pearson’s correlation coefficients and unadjusted p values were calculated to
better understand the relationships of the many self-rated measures.

Meditation home practice time was an important and objective measure of
adherence but was only obtained in those who were randomized to receive the
MM training after Visit 1. The association between meditation home practice time
and outcomes was assessed using a linear regression model with the dependent
variable being the Visit 2 – Visit 1 difference. In this analysis, only outcomes that
were significantly affected by MM in the above ANCOVA were evaluated.

Salivary cortisol was assessed at three time points following Visit 1 and Visit 2.
While multilevel mixed model analysis of cortisol data has been done previously
[262, 263], we chose a simple ANCOVA analysis since there were only three
data points. Outcomes were cortisol awakening response (CAR), the transient
increase in cortisol for about 30 minutes after awakening, and the difference
between the awakening cortisol minus the bedtime cortisol (slope). For the slope
calculation, the 30 minute after awakening cortisol collection for the CAR was
dropped as has been previously suggested [260, 263].

RESULTS
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Following telephone screenings, 134 participants came to Visit 1 and were
randomized to receive the MM beginning shortly after Visit 1 (n=66) or to wait-list
control in which they received the MM beginning shortly after Visit 2 (n=68)
(Figure 1). The participant demographics (Table 3.2) were mostly women as is
common for mind-body studies and overwhelmingly Caucasian non-Hispanic with
under-represented minority percentages comparable to Portland metropolitan
area statistics for this age range. Participants were also highly educated. Only
one participant was over age 75 years old. Participants were comparable in age,
gender, years of education or PSS at baseline between the two groups. There
were 60 participants returning to visit 2 in the MM group compared to all 68
participants in the wait-list group (P = 0.013).

Table 3.2. Participant demographics
Variable

Meditation

Wait-list

66 (51)

68 (56)

Age

60.2 + 7.4

59.4 + 6.3

Years of Education

17.0 + 2.5

16.4 + 2.8

3

1

African American

1

1

Asian

2

4

19.0 + 6.1

18.5 + 6.1

60

68

Number randomized (no. female)

Underrepresented groups (no.)
Hispanic

Perceived Stress Scale at Visit 1
Return at Visit 2 (no.)
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Figure 3.1. CONSORT figure.
The dropout rate by Visit 2 was only 4.5% out of 134, but the dropout rate was
higher in the MM group (Fisher’s Exact Test because of 0 dropouts in the wait-list
group , p=0.013). The 6 dropouts had characteristics roughly comparable to the
completers (age = 58.2 years, 4 women, education 14.5 years, and PSS 22.

Table 3.3. Outcome measures by group and effect size
Outcome
Measures

Visit 1
Mean (SD)

Visit 2
Mean (SD)

Visit 1
Mean (SD)

Visit 2
Mean (SD)
Unadj p

FDR p

adjusted
mean
differ.

24.8 (7.2)
18.7 (5.9)
17.6(8.5)
33.9(4.9)
28.6(7.5)
24.5(4.5)
27.4(5.5)
21.7(6.4)

20.7 (7.7)
15.2 (5.7)
12.4(7.6)
36.1(5.1)
31.0(6.3)
25.3(4.3)
28.0(5.3)
17.9(5.5)

24.4 (9.3)
18.5 (6.1)
19.4(10.5)
33.5(6.3)
31.1(7.1)
25.3(6.4)
26.6(5.8)
21.9(7.5)

23.6 (9.7)
18.5 (7.2)
18.5(10.9)
33.6(6.2)
30.7(7.3)
24.8(6.7)
26.5(5.1)
20.8(7.7)

.0001
.0001
.0002
.0006
.0003
.03
.10
.001

.001**
.001**
.002**
.003**
.002**
.09
.18
.005**

.12
.11
.11
.09
.10
.04
.02
.08

3.3
3.5
4.9
-2.2
-2.3
-1.3
-0.9
2.7

32.1(6.3)

33.1(6.0)

32.7(7.1)

32.1(6.0)

.07

.14

.03

-1.4

6.5(1.7)

6.3(1.7)

6.2(1.6)

6.3(1.5)

.46

.54

.01

0.2

14.3(3.4)

14.6(3.4)

14.5(3.3)

14.0(3.5)

.21

.33

.02

-0.7

29.6(3.5)
39.8(19.7)
50.4(6.5)
37.9(9.6)
8.5(3.3)
51.8(10.2)
30.1(6.5)

30.3(3.7)
51.3(21.7)
49.1(6.8)
44.3(9.8)
6.9(3.0)
57.6(10.1)
32.9(6.0)

30.1(4.2)
46.5(19.4)
50.2(6.7)
40.0(10.6)
8.4(3.2)
51.5(12.1)
29.5(7.0)

29.2(4.0)
48.2(20.3)
50.6(7.2)
40.3(11.5)
7.6(3.0)
54.8(11.2)
30.5(7.9)

.003
.002
.07
.00003
.08
.05
.06

.009*
.008*
.14
.001**
.16
.14
.14

.07
.08
.03
.13
.02
.03
.03

-1.5
8.3
1.6
-5.7
0.8
-2.6
-2.0

10.9(2.3)

11.5(2.7)

11.3(2.7)

11.6(2.7)

.61

.69

.00

-0.2

48.0(14.3)

46.9(13.4)

47.0(14.2)

49.5(14.2)

.13

.23

.03

3.2

21.4(5.9)

16.5(4.7)

21.4(5.6)

17.0(4.1)

.88

.94

.00

0.6

44.3(8.4)

46.4(7.6)

47.1(9.3)

49.1(7.5)

.37

.48

.01

1.1

49.0(8.3)

48.8(7.0)

46.6(9.8)

49.5(6.8)

.38

.48

.01

1.3
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Self-Rated
NEO- N
PSS
CESD1
NEO-A1
NEO-C
NEO-E
NEO-O
PANAS-neg
(trait)1
PANAS-pos1
(trait)
PANAS-neg
(state)1
PANAS-pos
(state)1
GPSE1
Sf-36 fatigue1
SF-36 PCS1
SF-36 MCS1
PSQI
MAAS1
FFMQ-NJ1
Cognitive
Letter Number
Sequencing1
Letter
fluency1
dyrs)
Category
fluency
Stroop CW
condition1
Stroop CW
interference

partial
eta
squared

Word listdelayed
Choice RT
(msec)1
Simple RT
(msec)1
Flanker RT
Incongruent
(msec)
Physiological
Respiration rate
1st five mins
Respiration rate
2nd five mins
Respiration rate
3rd five mins
CAR1
Cortisol slope1
Systolic bp
Diastolic bp
Heart rate
HRV SDRR
(msec)
HRV LF/HF
ratio1

6.8(2.0)

7.5(1.8)

6.8(2.0)

7.3(1.9)

.40

.49

.01

-0.2

470(67)

462(70)

463(70)

465(59)

.21

.33

.01

7.3

270(46)

267(43)

272(43)

279(40)

.07

.14

.03

10.0

753(107)

703(119)

792(165)

726(148)

.37

.4

.01

-3.6

14.3(2.9)

13.5(3.0)

14.1(2.9)

14.2(2.7)

.10

.18

.03

0.7

14.6(2.9)

13.7(3.1)

14.2(2.8)

14.5(2.6)

.05

.09

.04

0.9

14.8(2.8)

13.9(3.3)

13.9(2.9)

14.8(2.8)

.005

.01*

.09

1.5

.17(.21)
-.18(.27)
133(20)
81(13)
70(12)
42(21)

.13(.20)
-.23(.14)
128(20)
80(11)
69(12)
46(19)

.05(.46)
-.26(.20)
130(19)
80(12)
68(10)
41(24)

.12(.24)
-.18(.83)
128(16)
80(10)
68(10)
46(20)

.98
.07
.33
.33
.73
.99

.99
.14
.44
.44
.80
.99

.00
.03
.01
.01
.00
.00

-.01
0.1
1.5
0.5
0.4
0.0

1.9(1.5)

3.2(3.1)

2.5(2.1)

3.0(1.9)

.29

.43

.01

-0.5

Untransformed mean (standard deviation) of outcomes at the two visits by group. For ANCOVA group effect, there are
unadjusted (unadj.) p values, FDR adjusted p values across all outcomes, partial eta squared effect size, and adjusted
mean difference at Visit 2 (waitlist – MM). The number of participants for most analyses is 128. For FDR p values, *
p<.05 and ** p<.005.
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MM = mindfulness meditation intervention group; Unadj = unadjusted; FDR = False Discovery Rate; NEO =
Neuroticism-Extraversion-Openness Personality Inventory (-N = Neuroticism; -A = Agreeableness;
C=Conscientiousness; -E = Extraversion; -O = Openness); PSS = Perceived Stress Scale; CESD = Center for

Epidemiologic Studies Depression Scale; PANAS = Positive and Negative Affect Schedule (-neg = Negative Affect; pos = Positive Affect); GPSE = General Perceived Self-Efficacy; SF-36 = Short Form 36-item health-related quality of
life; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score; PSQI = Pittsburgh
Sleep Quality Inventory; MAAS = Mindful Attention Awareness Scale; FFMQ-NJ = Five Factor Mindfulness
Questionnaire—Non-Judgmental Factor; CW = Color Word; msec = milliseconds; RT = reaction time; mins = minutes;
CAR = Cortisol Awakening Response; bp = blood pressure; HRV = Heart Rate Variability; SDRR = Standard Deviation
of Inter-Beat Interval; LF = Low Frequency; HF = High Frequency.
1 Statistical

transformation was used.
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1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

1.NEOneuroticism

1

2.PSS

.60***

1

3.CESD

.68***

.74***

1

4.NEOagreeableness

.29**

.19*

.26**

1

-.34***

-.31***

-.33***

-.19*

1

-.52***

-.26**

-.36***

-.27**

.23*

1

-.11

.11

.05

-.12

-.14

.19*

1

8.PANAS-neg trait
(home)
9.PANAS-pos trait
(home)
10.PANAS-neg
state (lab)
11.PANAS-pos
state (lab)
12.GPSE

.71***

.57***

.64***

.33***

-.23*

-.29**

.02

1

-.62***

-.43***

-.48***

-.17*

.44***

.63***

.15

-.40***

1

.24*

.15

.25*

.16

-.08

-.08

-.07

.32**

-.08

1

-.11

-.12

-.05

-.00

.20*

.22*

-.07

-.06

.38***

.16

1

-.42***

-.31***

-.38***

-.18*

.35***

.34***

.03

-.36***

.51***

-.21*

.12

1

13.SF-36 Fatigue

-.49***

-.51***

-.53***

.05

.26**

.20*

-.03

-.47***

.47***

-.21*

.17

.12

1

14.SF-36 MHC

-.62***

-.61***

-.64***

-.17*

.31***

.28***

-.09

-.59***

.50***

-.15

.24*

.11

.69***

1

15.SF-36 PHC

.08

-.03

-.05

.04

.04

-.05

.07

-.04

-.04

-.15

-.21*

.28**

.12

-.30***

1

16.PSQI

.17*

.06

.18*

07

-.09

-.09

-.13

.18*

-.08

.07

..08

-.02

-.29**

-.12

-.19*

1

17.Mindfulness –
current moment
18.Mindfulness non-judgemental

-.38***

-.34***

-.33***

-.11

.30***

.16

-.08

-.33***

.27**

.08

.15

.16

.23*

-.08

.36***

-.08

1

-.61***

-.29***

-.41***

-.26**

.14

.29**

.08

-.52***

.23*

-.04

.08

.28**

.18*

-.04

.36***

-.14

.36***

5.NEO-Conscient.
6.NEOExtroversion
7.NEO-Openness

18

1

Table 3.4. Correlation matrix of all normalized self-rated outcome measures, with unadjusted p values * p<.05, ** p < .005, *** p < .0005
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Outcomes Analysis (Table 3.3)
The outcomes related to negative affect and stress were almost all highly
significantly improved from the MM intervention after adjusting for multiple
comparisons. This includes CESD, PANAS-negative (trait), and PSS with small
to moderate effect sizes (e.g., partial eta squared for CESD was 0.11). The
PANAS-positive was not significantly affected by the MM intervention. Although
the conventional PANAS-negative completed at home using conventional
questions was significantly affected by MM, the state PANAS filled out in the lab
setting demonstrated no significant change from the intervention for either
negative or positive affect. The test-retest reliability, as assessed by the
correlation of the measure at baseline Visit 1 with the measure at Visit 2, was
lower than for the PANAS state version than the trait version.

NEO personality traits were significantly affected by the intervention. NEO
Neuroticism was the a priori personality trait affected (p = 0.001) but other traits
also changed significantly, Agreeableness (p=0.003) and Conscientiousness
(p=0.002). There was no significant change of Extraversion or Openness.
The SF-36 Energy and Fatigue demonstrated significant improvement (p = .008).
The calculated Mental Health Composite also demonstrated significant
improvement (p<.0.001) but the Physical Health Composite did not. Self-efficacy
(GPSE) also improved with the intervention. Of note, the two mindfulness

80
measures were not significantly improved although there was a trend towards
improvement of the mindfulness-nonjudgmental factor. Subjective sleep quality
(PSQI) was not significantly improved. See Figure 3.4 for pairwise correlations
between all the self-rated measures. The correlations were very high for most of
the measures that were affected by the intervention suggesting some common
underlying factor may be assessed by all these measures.
There were no significant intervention effects on the cognitive battery, including
working memory (Letter Number Sequencing), Stroop test, verbal fluency
(semantic or category), immediate or delayed verbal memory (using CERAD
word list), flanker attention task, simple reaction time or choice reaction time.
Additionally, there were no significant effects on salivary cortisol (awakening
response or diurnal downward slope), heart rate, or heart rate variability. There
was a significant decrease in respiration rate in the MM compared to waitlist
group after 10 minutes of sitting and listening to an audio recording without
performing any task.
Adherence and home practice
Participants in the MM intervention attended all one-on-one training sessions
(these often required rescheduling) and practiced at home an average of 30.3
+/- 11.8 minutes per day. Using linear regression in the 60 participants who
received MM training before Visit 2, there was no relationship between minutes
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practiced and outcome measures that were significantly affected by the MM
intervention compared to wait-list.

DISCUSSION
This randomized controlled trial of six-week MM training compared to waitlist
control of 134 50-85 year olds was executed adequately, maintained blinding of
the assessors, and had a dropout rate of only 4% through Visit 2. The six
dropouts were disproportionately all in the MM group which may be related to the
fact that those in the waitlist group only needed attend the Visit 2 assessment to
receive the MM intervention and they did not need attend the six weekly training
sessions.
There were very significant improvements in most of the standardized, self-rated
measures related to negative mood and stress. Of note, there was no significant
effect for positive affect (PANAS-pos). Additionally, the assessment of stress
using the PANAS state 10-question version was not sensitive to intervention.
While the state version may be useful for ecological momentary assessment over
many assessments and days, it does have more intra-subject variability. This
may be related to the wording of the state assessment that asked “Right now I
feel ___ ?” in contrast to the more commonly used standard version that asked
“how you generally feel” or “how you feel on average”.
Neuroticism was specifically analyzed as an outcome even though it correlates
with other negative affect measures. While personality has been thought of more
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as a stable trait measure with genetic contributions, personality as assessed with
measures such as the NEO is affected by environmental influences and has
been reported to change both negatively with chronic caregiver stress [30] or
positively from a meditation intervention [264]. While Neuroticism was the most
altered of the personality traits (decreased), Conscientiousness and
Agreeableness also changed (increased) in response to the MM intervention;
Extraversion and Openness did not change.
The SF-36 health related quality of life demonstrated significant changes in the
Mental Health Composite and Vitality subscore. The average improvement in the
Mental Health Composite (6.4) was greater than the minimum clinically important
difference which is 4 [265] with the wait-list increasing by 0.3 and the average
improvement in the Vitality subscore was 11.5, more than the minimum clinically
important difference of about 9 [265] with the wait-list group increasing by 1.7.
The vitality component of the SF-36 was previously improved from a mind-body
intervention (yoga) in healthy older adults [242] and in people with multiple
sclerosis [241].
Self-efficacy (GPSE) improved from the intervention although less than some of
the negative affect measures. Subjective sleep quality (PSQI) did not improve
even though there has been suggestion of improved sleep in mind-body
interventions [248]. Our study participants were not recruited for sleep problems
although participants did have some sleep problems overall, with an average
PSQI at baseline of 8.4

83
With the exception of respiration rate, the cognitive and physiological outcomes
were not changed. The decline in respiration rate in the MM group was seen in
the third 5-minute block of sitting quietly listening to auditory recordings and it
may represent a specific training related change since awareness of breathing
was part of the training. This finding that meditation produced benefits in
psychological measures but not in objective physiological measures is consistent
with some meta-analyses of meditation interventions [225, 266]. However, this
trend in the literature contrasts with many individual MM intervention studies
demonstrating some effect on physiological and cognitive outcomes with
intervention lengths both longer and shorter than 6 weeks [98-105]. Due to the
wait-list only control it could be that some benefit of the MM compared to wait-list
may be related to simple attention and expectancy/placebo effects. The fact that
objective measures demonstrated less change than the subjective self-rated
measures, lends credibility to this possibility since placebo is known to have a
greater effect on subjective measures [115, 267]. However, some of the highly
standardized assessments such as Neuroticism are not generally known to have
significant improvements from any intervention, let alone demonstrate a placebo
effect. Also, the significant changes in the psychological measures were not
correlated with expectancy.
The lack of changes in cognitive outcomes despite the known relationships of
cognition to chronic stress especially with aging [26, 28, 117] is of interest since it
is known that excessive stress has a negative effect on cognitive function; thus,
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we must question why no changes were seen with improved self-rated stress.
The participants did not have pathological depression, PTSD, or anxiety
disorders that are more likely to produce impairments in cognition and so our
participants may have been performing at or near their maximal ability already.
Over the 2-month study, perhaps the selected cognitive measures were not
optimal even though it was a fairly broad battery with a focus on frontal/executive
measures that are known to be more sensitive to negative affect and stress. The
cognitive benefits of MM may be related to decreased mind-wandering [268
Hasenkamp, 2012 #5525, 269, 270] which may not be apparent in conventional
cognitive testing where high attentional focus is required only for relatively brief
periods.
There were essentially no changes in the physiological measures related to
stress. There were no changes in HRV (LF/HF ratio and standard deviation of
RR interval) or cortisol, which were strong theoretical candidates for sensitive
measures. We sampled cortisol only three times a day over two days at each of
the visits. This limitation in design was associated with poor intra-subject
reliability for test-retest, high inter-subject coefficient of variation, and limited
ability to calculate area under the curve or diurnal cortisol slope. Thus, the study
design may have been at least partially responsible for the lack of significant
change.
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The lack of major changes in objective measures in contrast to the self-rated
measures is likely not related only to placebo effect issues and potential
explanations are provided.
1) It is possible that the MM intervention was not a sufficiently long duration.
2) The one-on-one class is likely not ideal for all participants although it has
been quite acceptable and allows more flexibility in scheduling research
participants. A recent survey comparing on-line, one-on-one and group
delivery of meditation training suggested that one-on-one was at least as
favorable as group [231]. A group setting might have produced some
improvements because of group dynamics but group dynamics would add
experimental noise to the intervention, and a group setting is less
acceptable to some people, e.g., those with high introversion or PTSD.
3) There are many physiological measures related to stress [224] which may
increase due to a short term stressor but perhaps not decrease that much
secondary to a longer term stress-reducing intervention. Other
physiological changes not directly related to intracerebral processes such
as telomerase or what have been called allostatic load measures have
generally been more sensitive to longer term cross-sectional differences
[141, 180-183, 212, 271] and may have similarly low sensitivity to a broad
population intervention.
4) The outcomes may need to be measured over a much longer time frame
or follow-up since physiological changes related to stress improvement
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may take considerable time (Visit 2 was at two months). For example hair
cortisol and hippocampal size reflect stress-induced changes over a
longer term even though they are not necessarily sensitive to acute or
excessive transient responses [14, 166, 272].
5) The outcomes may not be optimally chosen or well-performed. While we
have previously demonstrated experimental and cross-sectional changes
in cortisol and heart rate variability [153, 273], cortisol is known to have
high test retest variability and sampling at only three time points on only
two days may be contributing to the absence of an intervention effect.
6.) Ecological Momentary Assessment (EMA) is different from the more
commonly performed single assessments especially if done in in the
laboratory environment. The laboratory induces an inherent change in
peoples’ state, and they are not exposed to the usual environmental
stressors that would demonstrate their negative emotional reactivity and
coping mechanisms. This is particularly problematic for studies involving
the effects of stress where EMA has been used [194, 195, 274, 275].
While the PANAS state version that would be closer to what is asked
using EMA had more intrasubject variability, recording it many times over
many days may actually capture reactivity to real-life stressors.
Additionally, EMA may be preferable because assessments in the
research lab setting may be unrealistic. For example, in a prior study of
stressed older adults (dementia caregivers), participants were often
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relieved to be away from their caregiving responsibilities for the time they
were in the laboratory and thus had lower stress in the lab compared to
home - in contrast to control subjects who had mildly increased stress in
lab compared to home [276].
7.) The improvements related to meditation may primarily improve
responsivity to stressor (resilience). The objective measures may need to
be direct measures of resilience to stress either with experimental
stressors or more sustained ecological momentary assessment. For
example, cortisol on an average assessment day may be less affected
than cortisol in response to a stressor.
8.) It is likely that some people do not improve as a result of MM training from
a physiological, cognitive, or even mental health perspective. It will be
useful to better define those most likely to respond to MM training.
9.) It is likely that different people have different physiological effects of
stress. For example, some people may develop stress effects on their
blood pressure, some on their gastrointestinal system, and some on their
cognitive function.
10.)

There is no way to assess the quality of meditation so it is possible

that the “dose” as measured in number of hours practiced was insufficient
in this study to induce cognitive or physiological changes.

As mentioned above , the optimal dose of meditation needed to induce stress-
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relieving cognitive or physiological effects is not known. Those in this MM study
practiced an average of 28 minutes per day during the 6-week intervention as
assessed by turning on the study iPod to listen to the guided meditation audio for
daily practice. Among the self-rated psychological measures that did
demonstrate improvement with MM training compared to wait-list, there was no
relationship of the degree of improvement with minutes practiced. There is little
empirical data to justify how long one should practice meditation to achieve
improvements in clinically relevant markers, and it would be helpful to have better
knowledge of the dose response effect.

There are several additional limitations of this study. The age range of the study
population was relatively narrow and participants were mostly Caucasian and
highly educated. While participants needed to report at least mild stress, they
were not allowed to have very significant stress attributable to conditions such as
generalized anxiety disorder, PTSD or untreated depression. The latter
populations may demonstrate different effects of MM on cognitive or
physiological outcomes.

This study demonstrated very significant improvement in many self-rated
measures related to negative affect and stress, including clinically significant
improvements in health-related quality of life and a decrease in neuroticism.
While possible explanations for the lack of changes in cognitive and physiological
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measures have already been discussed, there remains a need for more complex
experimental and analytical approaches to understand the improvement in
mental health from MM. Since reactivity to stress is a biologically complicated
system and different people have different physiological sequelae to stress,
researchers may well benefit from methodologies that generate more relevant
data and take better advantage of systems science methods and approaches
[119, 224].
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Chapter 4.
Predictors of improvements in mental health to mindfulness meditation
intervention in healthy, stressed older adults using decision tree machine
learning.

Objective: To determine if machine learning can generate a reliable classifier to
predict who will benefit from a mindfulness meditation (MM) intervention.
Methods: 134 stressed 50-85 year olds were randomized to an MM intervention
with six weekly one-on-one sessions with a trainer along with home practice or to
a wait-list control (ClinicalTrials.gov NCT01386060). Outcome measures were
assessed at baseline, Visit 2, and Visit 3 (two months apart). All participants
received the MM intervention either between baseline and Visit 2 or between
Visit 2 and Visit 3 (wait-list). A responder was defined by comparing their
baseline and immediate post-MM intervention data using a known minimum
clinically important difference of the SF-36 health related quality of life mental
health component. There were 121 participants who completed their MM training
with baseline assessments and post-MM outcomes. Seventeen potential
predictors included demographic information (gender, age, and years of
education) and selected self-rated baseline measures related to stress and
affect. Continuous predictors were normalized if necessary and all were
standardized using the Z transformation. Simple univariate statistical analysis
was performed to compare the values for the predictors in the responder and
non-responder groups. Next, nine predictors were chosen for the machine
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learning analysis based on other results and a priori rationales. In addition to
choosing nine predictors for the machine learning analysis, principal component
analysis (PCA) was performed on all 17 baseline measures to reduce the
number of input variables to the classifier. Classification was performed using
decision tree analysis with 10-fold cross-validation. The reliability of the classifier
was calculated as the mean and standard error across the classifiers.

Results. 121 participants completed their MM intervention having data from
before and after their meditation training. As defined using the SF-36 mental
health component, there were 61 responders and 60 non-responders. Univariate
statistical analysis of the baseline measures demonstrated significant differences
between the responder and non-responders in several measures including the
Positive and Negative Affect Schedule negative (PANAS-neg), SF-36 Mental
Health Component (SF36-MHC), SF-36 Energy, the maximum PANAS-neg
(state version) of four ecological momentary assessments using smartphones at
home, and Neuroticism-Extraversion-Openness (NEO) personality assessment
of neuroticism. Decision tree analyses using 4 or 9 a priori or PCA chosen
predictors were unable to achieve reliable classification rate of better than 65%.

Discussion: Several differences in predictor variable were observed between
responders and non-responders to a MM intervention but decision tree analysis
was unable to usefully predict who would respond to the intervention. Several
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limitations to the analysis and future directions are discussed.

Keywords (up to six)
Meditation, responder, decision tree machine learning, stress, mental
health, older adults

Abbreviations/acronyms
CESD – Center for Epidemiologic Studies Depression
EMA- ecological momentary assessment
GPSE – General Perceived Self-Efficacy
MM – mindfulness meditation
MHC – Mental Health Component (of the SF-36)
NEO – Neuroticism-Extraversion-Openness
PANAS – Positive and negative affect schedule
PANAS-neg-max – maximum PANAS-negative of the 4 at-home EMA
assessments
PCA – principal component analysis
PSQI - Pittsburgh Sleep Quality Inventory
PSS – Perceived Stress Scale
SF-36 – Short form 36-item health related quality of life
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Mindfulness meditation (MM) is a popular meditation approach that has already
been formally studied and applied in a variety of clinical conditions including
Post-Traumatic Stress Disorder, depression, pain, and stress.[75-83] However,
the evidence for efficacy has not been as compelling as it could be [84, 85] and
one possible explanation may be that not everyone will improve with MM training.
This analysis hopes to shed light on who may be most likely to benefit from MM
training.

The most evidence of benefits of MM intervention is from improvements in selfrated stress and mental health [86, 225]. Given the complexity of the stress
system including multiple causative factors, mediators and physiological outputs
[224, 277, 278], it is likely that some people benefit significantly while others may
not benefit at all. It would be helpful to know from a clinical perspective as well as
from a research perspective of better understanding the mechanism of MM
benefit, what factors might predict clinically significant improvements of MM.
Despite reported improvements following meditation interventions, there has
been limited research into what factors predict or moderate the benefits of MM.
At least some measures of baseline affect impact on response to meditation
treatment.
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This analysis was performed to determine if and which baseline assessments will
predict who may most likely be a responder, i.e., benefit from MM training. The
prediction analysis utilized a machine learning approach, more specifically
decision-tree analysis [279].

METHODS.
Participants
Participants consisted of generally healthy adults 50-85 years of age who
reported at least mild levels of stress. Participants were recruited from the
greater Portland, Oregon metropolitan area. Following inquiries, participants
were told about the study and eligibility criteria. If interested, they underwent a
30-minute telephone inclusion screening for which there was an IRB-approved
Waiver of Authorization. This study was approved by the Oregon Health &
Sciences University Institutional Review Board (IRB) and was registered with
ClinicalTrials.gov (NCT01386060). Participants provided informed consent at
Visit 1 at the research lab. Exclusion criteria were primarily to screen out an
underlying illness that might limit the benefit of the intervention, confound
outcomes, or increase the likelihood of dropout (Table 4.1).
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Table 4.1. Inclusion and exclusion criteria
Inclusion
Criteria





Exclusion 
Criteria


Age 50-85 years old;
Baseline Perceived Stress Scale (PSS) [228] score ≥ 9;
Agree to follow the study protocol including randomization;
.
Cognitive impairment (significant participant complaints) or a
score of less < 30 on the Modified Telephone Interview for
Cognitive Status (TICS-m) [229]
Significant patient-reported medical/neurologic disease (e.g.,
major organ failure; insulin-dependent diabetes, active cancer,
or alcoholism);



Significant, untreated depression. Significant was defined
based on Geriatric Depression Scale greater than 5 and
interview;



Take medications known to affect CNS function or impact
physiologic measures (e.g., steroids, neuroleptics or regular
narcotic analgesics); stable doses of CNS-active drugs with
less impact (e.g., beta-blockers, SSRI’s, and histamine
blockers) were acceptable; enrolled participants were
encouraged not to change their drug use during the study
period and to inform the investigator if any change was made.



Cannot understand the instructions (e.g., cannot hear or see
study materials or not fluent in English);



Prior experience with meditation classes or other mind-body
classes (e.g., yoga or tai chi) within the last 24 months or more
than 5 minutes daily practice in the last 30 days.

Following Visit 1, all randomizations were performed by non-blinded research
personnel using a computerized covariate adaptive randomization procedure
[230] aimed at balancing active and waitlist groups on age, gender, and baseline
Perceived Stress Scale score using a pre-determined projected median split for
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the continuous measures. The researcher who led the meditation training
sessions performed the randomization, and the research assistants who
conducted data-collection visits remained blinded. There were three testing visits
(Figure 4.1), each 2 months apart, and all participants received a 6-week MM
training either between Visits 1 and 2 or between Visits 2 and 3 (wait-list control).
Participants who received the intervention post-Visit 2 served as a wait-list
control for the primary outcome analyses at Visit 2 previously described in
chapter 3. For the definition of responder for this analysis, pre-MM intervention
data were subtracted from the immediate post-MM data.

Intervention
The MM intervention was administered in six, one-on-one sessions occurring
weekly either between Visit 1 and Visit 2, or between Visit 2 and Visit 3 (wait-list
control). More details of the intervention that was a standardized and structured
program based on Mindfulness Based Cognitive Therapy [232, 233] are
described in Chapter 3 and a prior publication [280]. An unblinded RA delivered
the one-on-one training sessions but the assessments were performed by
blinded RAs. In addition to the six 60-90 minute training sessions, daily guided
meditations for home practice were accessed with a study iPod and adherence
tracked with developed software, iMINDr [281]. Participants were instructed to
practice at home up to 30 minutes a day as a goal but at least do some daily
practice. MM sessions offered strategies other than meditation for practicing
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mindfulness skills to cope with the many stressors that adults typically face.
Participants who were randomized to the Wait-list arm between Visit 1 and Visit 2
received the MM intervention after the wait-list period (between Visit 2 and Visit
3). All participants randomized to wait-list group had the same MM training in the
Visit 2-Visit 3 period as those randomized to receive MM immediately after Visit
1.

ANALYSIS
This is an exploratory analysis to determine if one can predict who will improve
from MM training and, if so, which predictor variables contribute to this classifier.
The outcome variable that demonstrated the greatest effect size in the previous
analyses (Chapter 3) and is also moderately clinically significant was used to
define “responder” based on their improvement immediately following MM
training.

Outcomes used to define responder
For more detail of the outcomes, some of which are also used as predictors
when measured at baseline, please refer to Chapter 3. Further details of the
specific measure used to define who was a responder and predictors of being a
responder are given below. For this analysis, a responder is someone who
achieved a minimum clinically important difference improvement in SF-36 Mental
Health Component which is 4 [265].
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Predictors
Since there were only 121 participants in this analysis, a decision was made to
limit the machine learning analysis to only 9 predictors. One set of analyses
utilized nine predictors chosen based on a priori hypotheses. Another set of
analyses was performed using only nine final predictors but chosen instead
based on principal component analysis (PCA) so all demographic and self-rated
psychological measures could be potentially included in the analysis. A second
set of analyses were performed with just 4 predictors in case there were
limitations in machine learning related to overfitting or to multicollinearity of the
input predictors. All participants who completed the MM intervention were used
for these analyses.

Demographic measures were gender, age, years of education, annual income
and lifetime exposure to stressful events measure [282].

Self-rated measures obtained at baseline Visit 1 and potentially entered into the
predictor analysis are self-rated measures that might affect responsiveness to
the MM intervention.
 Stress. The Perceived Stress Scale [228] and the PANAS [236] were
administered. At home on a Smartphone assessment tool, participants answered
the state question PANAS [236, 238] a reduced 10-question version [239] four
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semi-random times over waking hours, and the maximum PANAS-negative
across the home assessments at baseline was used as a predictor.


Neuroticism. While neuroticism has been considered a stable trait, changes

in neuroticism are a possible outcome from meditation studies [42, 212].
Neuroticism assessed with the current NEO [202] is used both as a predictor as
well as helping to define one of the secondary responder definitions.
 Mood. Depression was assessed by the Center for Epidemiologic Studies
Depression Scale (CESD) [237].
 Fatigue. The 4-question Energy and Fatigue subscale of the SF-36 healthrelated quality of life [240] that was previously found to be sensitive to yoga in
two prior studies [241, 242] may be a predictor of responsiveness.
 Self-efficacy. A measure of self-efficacy, the General Perceived Self-Efficacy
Scale [244], was included because of participants’ reporting their sense of control
was significantly affected by meditation [107, 245, 246].
 Mindfulness. A measure of mindfulness from the Five Factor Mindfulness
Questionnaire [88] was used as a predictor. Factor 5, mindful non-judging, was
used because it was found in prior studies to be significantly different in
chronically stressed populations, i.e., it was different between veterans with and
without post-traumatic stress-disorder [211] and between dementia caregivers
and non-caregivers [30].
 Stressful life events experienced measure was assessed with the Life
Experiences Survey [282].
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 Expectancy/Credibility was assessed [250] by using the sum of the
components.

Analysis: Conventional descriptive statistics
For descriptive purposes, the means of the 15 baseline continuous predictors
were compared between the responders and non-responder groups using t-tests
with unadjusted p values calculated as well as false discovery rates. Income that
was assessed using a 7-step scale was compared using Wilcoxon rank order
and the distribution of gender was assessed using chi-square.
Analysis: Machine learning approach.
Data processing was first performed in Stata 14 (StataCorp, College Station TX).
All predictors and the outcomes to be predicted were checked for normality using
Shapiro-Wilk and transformed if distributions were not normal (e.g., square root
or Box-Cox to correct for skewness) even though this likely would not impact the
decision tree analysis. The rest of the analyses were performed in Matlab
(MathWorks, Natick, MA) including the Statistics and Machine Learning Toolbox.
All baseline predictor measures were next standardized by dividing by the
baseline predictor standard deviation across all the participants.

The classifier used decision tree analysis for classification of responder or nonresponder as defined above. Decision tree analysis was chosen in part because
of the small sample size, its ability to deal with missing data, and because the
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decision tree is more interpretable to other researchers in the field as compared
to other approaches such as support vector machine. Of note, PCA without
rotation or other adjustment may negate the interpretability benefit. The Matlab
function fitctree uses a greedy decision algorithm based on iterative
dichomitization (ID3) [283] and with other enhancements or additions including
how decisions regarding split nodes are made (e.g., information gain or Gini
index) and pruning. The greedy ID3 algorithm, that takes the feature for the next
node with the highest information gain, will tend to overfit so performance often
benefits from pruning (developed in the C4.5 algorithm). The algorithm copes
with missing predictor values by using all available relevant data to evaluate a
specific branch point although it cannot utilize participants with missing
classification of responder status data.

For the first set of analyses, nine predictors were chosen that had the best a
priori rationale based on previous literature and knowledge of the predictors and
outcome: age, years of education, stressor life events, non-judgmental
mindfulness, Pittsburgh Sleep Quality Index, NEO-neuroticism, SF-36 Energy
and Fatigue, Expectancy, and maximum PANAS-negative using smart-phone at
home assessments. Since overfitting is a concern, similar analyses were
performed with only four predictors: life events, SF-36 Energy and Fatigue, NEOneuroticism, and expectancy, For the second set of analyses, dimensionality
reduction was performed by applying PCA to all the baseline measures (17) and
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using the participant data from the nine components with the highest variance
explained. The full data set of 17 predictor measures with only 121 participants
may not generate the best classifier because of overfitting and because of errors
in decision tree learning related to multicollinearity. These issues may well occur
with only nine predictors as well even though there would be greater than 10
observations per predictor variable (an acceptable recommended number). Thus,
a similar analysis was performed with just the four components with the most
variance explained.

There were several hyperparameters for the decision tree analyses that needed
to be defined including tree depth using maximum number of splits and minimum
parent size as well as split criteria (maximum deviance reduction/cross-entropy
vs Gini index). Of note, fitctree forces the minimum parent size MinParentSize) to
be linked to minimum number of leaf node observations size (MinLeafSize), i.e.,
MinParentSize = max(MinParentSize, 2*MinLeafSize). Thus parent size cannot
be modified independently of leaf size and the two potential parameters
represent only one actual hyperparameter. Since there was concern about trying
to define too many hyperparameters even before generating the decision tree
classifier given the small data set, two parameters were defined a priori: the split
criterion was the maximum deviance reduction and pruning was set to “on” which
only sets the optimal sequence of pruned subtrees. Given the limited data set
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size, the Matlab default tree definition parameters were chosen for the other
hyperparameters.

Once the hyperparameters were decided on, the model was generated using the
full data set (n=121). The reliability of the classifier was evaluated by using a 10fold cross-validation and generating the mean of the classification error along
with the standard error using the Matlab function cvloss. Since one goal was to
help predict who will most likely benefit from MM training, the average
information gain from the predictors in any useful classifier would be determined
along with their mean and standard error.

RESULTS
See Figure 4.1 for the clinical trial study design with recruitment, randomization,
and drop-out numbers. See table 4.2 for demographics and selected baseline
measures for all participants who completed their MM training and were used for
these analyses. Of the 121 completers, the average age was 60 years and 79%
were women. Half were considered responders based on the SF-36 mental
health component. The completers practiced meditation 27.0 + 10.7 mins per day
during their intervention period.
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Figure 4.1. Consort table.
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Table 4.2. Demographics and predictor variables. Mean (standard deviation)
grouped by responder status as defined by the minimum clinically important
difference of the SF-36 MHC from the 121 participants who completed the MM
intervention. Statistics comparing the 2 groups are given (by t for all except chisquare for gender and Wilcoxon rank order for 7-step income) and associated p
values and false discovery rate adjusted p values.
SF36-MHC
responder
n=61

SF-36 MHC
nonresponder
n=60

Female (%)

51 (84%)

45 (75%)

Age (years)
Years of
Education
Income (7
steps)
Life Event
stressors
PSS
(baseline)
PANAS-neg

59.0 (6.7)

60.8 (7.1)

16.9 (2.9)

16.6 (2.4)

4.6 (2.1)

4.3 (2.0)

-10.4

-6.9

19.0 (6.1)

17.8 (5.5)

23.2 (7.9)

PANAS-pos
PANAS-negmax home
NEOneuroticism
CESD
SF-36 MHC

Statistic, p value,
and FDR adjusted p
value
1.37

p=0.24

0.47

-1.37

p=.17

0.41

0.60

p = .55

-.62

0.78

p = 0.43

0.53

-1.58

p=0.12

0.34

1.07

p = 0.29

0.47

19.8 (5.4)

2.77

p = 0.0065*

0.04*

32.4 (6.9)

33.3 (6.0)

-0.77

p = 0.44

0.53

8.6 (3.2)

7.3 (2.3)

2.40

p = 0.018*

0.08

25.8 (8.2)

22.8 (8.2)

1.98

p = .05*

0.17

18.9 (10.5)

17.0 (9.4)

1.16

p=0.25

0.47

36.1 (9.5)

42.7 (9.8)

-3.77

p = 0.0003*

0.005*

SF-36 Energy 38.9 (19.1)

48.9 (19.7)

-3.1

p= .005*

0.03*

GPSE

29.7 (4.2)

30.3 (3.5)

-0.97

p = .33

0.47

PSQI
Mindfulnessnonjudgmental
Expectancy

8.3 (3.0)

8.3 (3.5)

-0.01

p=0.99

0.99

-0.97

p = 0.33

0.47

0.31

p =0.75

0.80

29.4 (6.4)

30.5 (6.8)

28.6 (5.8)

28.3 (6.4)
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MHC- mental health component of SF-36 health related quality of life; FDR =
False Discovery Rate; PSS = Perceived Stress Scale; PANAS = Positive and
Negative Affect Schedule (-neg = Negative Affect; -pos = Positive Affect); NEO =
Neuroticism-Extraversion-Openness Personality Inventory; CESD = Center for
Epidemiologic Studies Depression Scale; SF-36 = Short Form health related
quality of life; GPSE = General Perceived Self-Efficacy; SF-36 = Short Form 36item health-related quality of life; PSQI = Pittsburgh Sleep Quality Inventory.
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The results from conventional univariate biostatistics are shown in Table 4.2.
Several of the predictors were significantly different between the two groups, i.e.,
PANAS-neg, PANAS-neg-max at home, NEO-neuroticism, SF-36-mhc, and
SF36-energy and three remained significant after correction using the false
discovery rate: SF-36-mhc, SF-36-energy, and PANAS-neg.

The hyperparameter settings of tree depth and minimum parent size had little
effect on the overall accuracy.
Although these settings were occasionally altered for exploratory purposes, the
Matlab default settings were used for final analyses. Following the definition of
the hyperparameters, the decision tree analysis utilized the nine measures that
were most statistically different in the responder and non-responder groups: Life
Events, age, gender, CESD, SF36-mhc SF-36-energy, NEO-neuroticism,
PANAS-neg, and the PANAS_neg-max at home.. The decision tree generated
from the full data set generated a mean error rate of 0.388 using 10-fold crossvalidation with a standard error of 0.04. By altering input variables the decision
tree was able to achieve up to a 0.347 error rate with cross-validation (standard
error 0.04) but some decision trees still ended up with error rates of up to 0.444
using 10-fold cross-validation with a similar standard error. Since overfitting was
always a concern, the same analysis was also done with only 4 predictors. These
decision tree classifier results were similar to those already described with 10-
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fold cross-validation error rates of 0.41 and standard error of 0.04 across 10-fold
cross validation.

The next step in the analysis was to use PCA to reduce the number of variables
and try to capture the most unexplained variance. For this measure calculation
gender was not entered and the 9 components with the highest amount of
variance explained were chosen. The error rates were not improved (0.46 +/.04). Even reducing the number of variables again, by using just the 4
components with the most variance explained, did not produce any significant
improvement.
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Figure 4.2. Example of decision tree classification. One decision tree in the
analysis using 4 predictors yielding a 10-fold cross-validation error rate of 45%.+
3%. Fitctree settings were maximum number of splits = 5 and minimum parent
size = 4. 1 is responder to MM training and 2 is a non-responder. This is level
one pruning with one node eliminated. The 4 predictors entered in this analysis
were Neurot = NEO-neuroticism, panasnegmx= maximum PANAS-neg from the
4 at home ecological momentary assessments, Life Events, and expectancy,
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DISCUSSION
Analysis of the responders and non-responders to MM training revealed several
significant differences in baseline measures. More specifically, those who
improved from MM training had worse mental health prior to randomization than
those who did not respond. The mental health measures that were different at
baseline were the PANAS-neg, NEO-neuroticism, SF-36 Energy and Fatigue,
and the SF-36 Mental Health Component, the latter also being what was used to
define a responder. Machine learning using decision tree analysis to predict
whether or not participant’s mental health would improve following MM training
had limited ability to correctly classify a participant as a responder or nonresponder, with accuracy rates below 70% for almost all of the analyses and
sometimes below 60%. The baseline measures that did appear in the decision
tree classifiers were the ones already mentioned that were different at baseline
using univariate statistics. The only other measures that occasionally appeared in
the classifiers were the Life Events and expectancy measures. Mindfulness (nonjudgmental), positive affect, sleep quality, and self-efficacy were also not useful
at differentiating responder status. None of the demographic predictors including
age, income, and gender were useful and they did not enter into the decision
trees. Additionally, none of these latter measures were significantly different in
responder and non-responder groups using conventional biostatistics (all p’s
greater than 0.2). Besides the present study showing that those with worse
mental health improve more from a meditation intervention, other studies
described below have also observed that those with worse mental health at
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baseline are more likely to demonstrate improvements from a meditation
intervention.

One study looking specifically at the outcome of relapse in depression, observed
that Mindfulness-Based Cognitive Therapy was most effective in those who had
already had three or more episodes of depression and also in those whose
depression was not preceded by life events [284]. One study did observe an
increased effect of meditation intervention on mental distress and well-being in
those with higher neuroticism [285]. Personality traits have been observed to
potentially be a factor in response to other mind-body therapies as well.
Qualitative analysis (participant interview) suggested that some personality traits
may predict who would respond to broader integrative medicine approach
including yoga for asthma management [286]. One paper found those with
greater mindfulness had greater declines in perceived stress at one year
following the MM intervention [287]. The fact that those who responded to the
intervention had greater fatigue at baseline is of interest. Also, of the measures
that were different in the responder and non-responder groups, we had
previously shown that the SF-36 Energy and Fatigue subscore was sensitive to a
mind-body intervention in two randomized controlled trials of 6 months of yoga
compared to control, one in a group of 69 people with multiple sclerosis [288] and
one in a group of 135 healthy older adults.[242].
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At least one other study also found no relationship of outcomes to baseline
demographic factors, i.e., there was no relationship of demographics, baseline
spirituality, or trait mindfulness on the decrease in depressive symptoms
following MBSR [289]. Some researchers have simply determined changes in
non-primary outcome measures, potentially at an earlier point in time than the
final outcome measures, to see if those may predict outcome measure changes
[113, 290], but this approach is inherently different than trying to determine
predictors at baseline prior to the intervention.

Expectancy has an impact on many outcomes, self-rated outcomes in particular
[115, 267]. In regards to meditation, patients with cancer had greater
improvement if they were assigned to their program preference whatever
program they happened to be randomized to: Mindfulness-Based Cancer
Recovery, Supportive Expressive Therapy or a stress management seminar
[291]. Of note, the mindfulness intervention was the most preferred program, but
those randomized to their preferred intervention improved more over time on
quality of life regardless of actual intervention type. Women with greater
psychological morbidity at baseline showed greater improvement in stress
symptoms and quality of life if they received their preferred vs non-preferred
program [291]
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In addition to studies discussing baseline factors that relate to improvements
from the meditation interventions, there have been previous studies of MM that
discussed factors associated with adherence to the MM intervention. Predicting
adherence may be important since adherence to meditation practice [292] or
adherence to any intervention including taking placebo may correlate with better
outcomes [115]. Most studies related to adherence to a meditation intervention
predictor identify factors, e.g., comorbid personality disorders, associated with
completing the intervention [113]. It is known that there are a number of other
factors associated with adherence to mind-body interventions which may impact
outcomes [293]. This has even been extended to fMRI activation in selected
brain regions predicting engagement with meditation techniques [294].
Additionally in terms of predicting adherence, the degree of stress-related
physiological responses did not predict amount of meditation practice time even
though the physiological measures did respond to the meditation intervention
[295]. Furthermore, unrealistic positive expectations have not been found to
relate to meditation practice [296]. A larger study evaluating factors predicting
barriers to meditation practice found no impact of age but did find an impact of
personality trait (Conscientiousness, Neuroticism, and Openness) [297].

There were several limitations to this study. Having only a wait-list control implies
that some benefit of the MM compared to wait-wait-list may be related to placebo
effects [115]. If this were the case, there would be two types of response
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contributing to the outcome analysis: 1) placebo responsiveness predicted by
certain variables such as expectancy, and 2) responsiveness to the MM
intervention predicted by other variables such as mental health. The number of
observations (participants) is small for a machine learning approach even though
the analysis limited the number of predictors to nine so that there were more than
10 observations per variable in the training set. Decision tree analysis might have
slightly benefited from methods such as ensemble learning or AdaBoost [298]
methods. Additionally, decision tree analysis may not be the best machine
learning approach for this data set [299]. Also, adding costs or penalties of
allocation and misallocation to the decision analysis might make the analysis
more interpretable but at this low level of classification accuracy it was not likely
to be useful. A more general issue with predictor analysis in clinical trials is that
responder status is subject to a “regression to the mean” effect, especially since
many of the predictor variables are correlated to the SF-36 MHC score. Thus,
those with lower SF-36 MHC will be more likely to improve, and many of the selfrated predictors are correlated with the SF-36 MHC (e.g., SF-36 energy, NEOneuroticism, PANAS-neg). One prior study did suggest that regression to the
mean is not the only explanation of beneficial MM effects. People with panic
disorder receiving mindfulness-based cognitive therapy demonstrated greater
improvements in their panic disorder symptoms if they were less depressed at
baseline based on Hamilton Depression Rating Scale [113]. This implies that the
responders had some relevant characteristic to predict responsiveness and,
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given the pattern of changes, it was not simply demonstrating regression to the
mean for people who have more extreme baseline values. Additionally, while not
the focus of this paper, the participants in the wait-list control arm of this study
had no major changes in their measures of stress and negative affect during the
wait-list period (Visit 1 to Visit 2) also suggesting that regression to the mean is
not the only issue. An additional limitation of the study is the lack of variability in
the study sample demographics consisting of mostly highly educated women in a
relatively narrow age range (50-85 years old) may limit both the quantitative
analysis and the generalizability. The prevalence of women is common in mindbody intervention studies. Broader inclusion criteria for the next study would be
helpful.

Future directions include the need to improve predictor analysis. Even though
simple univariate analyses demonstrated that some baseline predictors were
significantly different in the responder and non-responder groups (NEOneuroticism, maximum PANAS-neg at home, SF-36 Energy and Fatigue), the
decision-tree analysis was not useful for classification. Interactions of the
variables may need to be better captured. Machine learning is a broad field and
other techniques may be better for this type of data [299-301]. Additionally, it is
likely that these particular predictor variables are not capturing salient properties
of a person vis-a-vis responding to MM intervention due to the dynamic character
of MM. Stress reactivity rather than simply perceived stress or mental health
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reflecting traits over some time may better capture the stress reactivity that
participants are taught in order to decrease the non-judgmental aspect of
mindfulness meditation training. These characteristics may need to be captured
by more prolonged assessments using ecological momentary assessment, or
assessing stress reactivity using experimental stressors in a lab setting.

In summary, even though simple univariate statistics demonstrated some
differences in baseline measures between responders and non-responders,
classification accuracy using decision tree analysis was less than 70%.
Demographic variables were particularly not useful at predicting outcomes.
Improving the classification using other statistical or machine learning
approaches or adding other predictor variables will be a useful future direction.
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Chapter 5.
Discussion

The first paper in this dissertation discussed the complexity of the human stress
system, including characterization of a stressor and the human physiology that
responds to a stressor. There are several issues that are important especially
from the systems science perspective that are reiterated or expanded here. 1)
The human physiological system has many components that are altered by any
stressor (see chapter 2, Figure 2.3). 2) The definition of a stressor event is not
purely objective, i.e., there is no quantifiable metric of stressor severity that does
not include individual aspects of the person since the effects of a stressor are
highly dependent on an individual’s perception. This subjective perception is
dependent on issues such as learning, e.g., the effects of major trauma and
conditioning, and genes or related systems, e.g., aspects of genetics,
epigenetics, proteomics, and metabolomics, especially as related to
neurotransmitter function and environmental reactivity. Event perception is also
dependent on the specific environment in which the human exists although this
could be considered an aspect of the stressor. For example the sound of a
gunshot in a rifle range has a different significance than the same sound heard in
a clothing store. A transient, i.e., not sustained, stressor impacts multiple human
physiological measures and these transient state changes are often associated
with physiological changes that are adaptive in nature. Perhaps the most wellknown response to a stressor is the autonomic nervous system increasing heart
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rate and blood pressure to allow for improved ability for “fight or flight”. However,
if these responses are too sustained, then chronic hypertension or vascular
disease may result. The cumulative or chronic effect of the changes to the
human system resulting from repeated stressors is referred to as allostatic load
by some [27]. Besides the more objective physiological changes, there are
psychological changes sometimes referred to as “burnout” that have some
degree of physiological correlates. These chronic changes to the person that
may impact future responses to stressors can be thought of as trait changes to
psychologists or parameter changes by systems scientists in contrast to more
transient effects referred to as changes in state to psychologists or variables to
systems scientists. The cost to system, i.e., the detrimental cost to the human of
making these changes to their physiological system, depends on the magnitude
and duration of the stressor (see Figure 2.4, Chapter 2).

In general, it is important to consider the degree of the stressor and the time
course of the stressor when thinking about how the stressor effects humans.
Some degree of stress may be important for the human so as to maintain
adaptability and maximize performance. In terms of maximizing performance, the
best athletic performances are often when a race or competition is particularly
close. In terms of maintaining adaptability, making changes in the physiological
system in response to a moderate stressor that is not sufficient to cause
immediate harm may be beneficial. Exposure to an intermittent low level of a
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stressor increases future ability to compensate to a future stressor without any
decrement in utility because of adaptive changes to the physiological system and
such system “learning” has been called hormesis [65]. For example, exposure to
an intermittent low level of a toxin may allow a person to tolerate what would
normally be a lethal dose and sometimes simple learning in response to a novel
stressor may improve ability to learn to respond to future stressors. In general,
acute mild or moderate stressors usually do not produce long-term negative
effects although a significantly powerful acute stressor may actually push the
brain dynamical system into a new, functional attractor basin with lower overall
utility.

On the other hand, chronic psychological stress often produces changes in the
system, such as a slower response to a future stressor or a higher potential for
moving to a new lower utility attractor basin. As already mentioned, this has been
referred to as allostatic load. Also, if a human is exposed to a “tolerable” dose of
a stressor that results in return to the original high utility attractor basin, the
outcome may be improved resilience. This balance between experiencing
sufficient stressors to keep one’s physiological system adaptive or resilient
versus experiencing declining health due to the cost of generating stressor
responses is the reason for the inverted U-shaped effect of stress on function
[277].
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From a systems science perspective, behavioral and physiological
measurements attempting to capture the degree of stress of a system need to go
beyond static objective measurements. One needs to incorporate the dynamics
of the physiological stress response system as well as measures of the
environmental stressors and their perception. Understanding stress will require
all of the interacting components from Chapter 2 Figure 2.3 to be measured
empirically and described, at least partially. With regard to developing useful
models of the systems dynamics of human stress physiology, there is a paucity
of empirical data regarding the temporal aspects of the human stress response
because it is difficult to acquire the human data. Nevertheless, acquiring and
analyzing dynamical data will be important to better understand stress physiology
since the timing and strength of feedback loops likely contributes to stressrelated disorders and resilience to stressors. In addition to measuring stress
responses over time, it may be useful to repeat administration of experimental
stressors to better understand self-reinforcing loops. These systems science
concepts and better measurement techniques will lead to improved
understanding of the stress system, increased resilience of the human system,
and better long-term health.

With the knowledge of the human stress system, the third chapter describes a
clinical experiment involving 134 at least mildly stressed older adults to evaluate
the effects of a stress-reducing intervention on psychological and physiological
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markers. A randomized controlled clinical trial of a mindfulness meditation (MM)
intervention was successfully implemented with a very low dropout rate. There
were many outcome measures and there were very significant beneficial effects
on many self-rated measures related to negative affect, stress, and mental
health. The effect sizes of the various outcome measures were in the small to
medium range with partial eta squared’s ranging up to 0.13. The effect size
reached a level above the minimal clinically important difference in the widely
used mental health component score of the SF-36 health related quality of life
measure. Despite the significant changes in mental health measures, there were
no significant changes in the objective outcome assessments (i.e., not self-rated)
of cognition, autonomic nervous system (heart rate and heart rate variability) and
hypothalamic-pituitary-adrenal axis (cortisol).

Despite the negative findings concerning the objective measures in this study, it
is still important to move beyond self-rated beneficial changes in stress and affect
for two reasons. The first is to ensure that the benefits observed are not simply
related to non-specific placebo or expectancy effects, and the second is to better
understand the mechanism of MM benefits. Increasing our understanding the
mechanism requires us to determine why there was a lack of changes in the
objective measures of stress and cognition despite the significant improvements
in self-rated measures of stress and affect. This discrepancy may relate to the
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specifics of the particular intervention and/or outcome measurements, but also
how one goes about assessing the stress system.

In terms of the intervention, it is possible the MM intervention was not as
powerful as it could be but that wouldn’t by itself explain the contrast in
outcomes. Additionally, there is no way to assess the quality of meditation so it is
possible that the meditation “dose” in this study was insufficient to induce
cognitive or physiological changes. Of note, there was no relationship between
simple minutes practiced and improvement in the outcome measures that did
improve as a group.

There are many physiological measures related to stress described in Chapter 2
[224] and, while many of these may be sensitive to a short term stressor they
may not be influenced by a longer-term stress-reducing MM intervention, MM. It
is possible that the simple measures of autonomic nervous system and
hypothalamic-pituitary-adrenal axis were not sufficiently sensitive. Other
physiological changes not directly related to intracerebral processes such as
telomerase and those referred to as allostatic load measures have mostly been
reported to be sensitive to cross-sectional differences [141, 180-183, 212, 271]
and may have similarly low sensitivity to an MM intervention. Assessing brain
changes more directly in humans is possible with certain techniques, such as
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EEG or MRI, but it is not possible to directly assess neurotransmitters as is done
in non-human experimental subjects [278, 302].

Another possible reason for the discrepancy in outcomes may relate to the time
course of the changes. It is possible that the intervention was not a sufficiently
long duration. The outcomes may need to be measured over a much longer time
frame or follow-up since physiological improvements related to stress
improvement may not be so immediate (Visit 2 was at two months). For example,
hair cortisol and hippocampal size reflect stress-induced changes over the long
term but are not necessarily sensitive to acute or excessive transient responses
[14, 166, 272]. The improvements related to meditation may primarily decrease
responsivity to a stressor (resilience). The objective measures may need to
measure resilience to stress either with experimental stressors or to consist of
longer-duration assessments, e.g., using ecological momentary assessment over
weeks or months. For example, cortisol on a typical assessment day may be less
affected than the transient amplitude or the time course of cortisol changes in
response to a stressor.

While possible explanations for the lack of changes in cognitive and physiological
measures have already been discussed, it is becoming evident that more
complex experimental and analytical approaches are needed to understand the
MM-induced improvement in mental health and reductions in stress and negative
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affect. Since reactivity to stress is a biologically complicated system and different
people have different physiological sequelae to stress, researchers may well
benefit from systems science methodologies to evaluate tightly coupled data
taking into account the temporal aspect of the stressors and the varying time
course of resulting changes in human physiology [119, 224].

Another approach to understanding the mechanisms by which MM moderates
stress responses in human is described in detail in Chapter 4. In order to better
understand the impact of stress on the human physiological system, it would be
helpful to better understand the mechanisms of how a clinical intervention
improves affect and perceived stress. More specifically, since MM was shown in
Chapter 3 to improve outcome measures related to negative affect and perceived
stress, the analysis in Chapter 4 determined what baseline personal factors
would be able to predict the person’s responsiveness to a MM intervention. It
was hoped that understanding the predictors of who improved might shed light
on the underlying mechanisms of MM benefits especially the puzzling fact that
subjective measures improved but the objective measures did not (cognition,
cortisol, heart rate and heart rate variability). Potential predictors for this study
included demographic information (gender, age, income, years of education and
exposure to life events) and selected baseline self-rated measures related to
stress and affect.
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The outcome chosen for the predictor analysis was the mental health component
of the SF-36 health related quality of life measure since it had the largest effect
size in the chapter 3 study and the adjusted mean difference compared to the
waitlist control arm exceeded the minimum clinically important difference.
Analysis of the responders and non-responders to MM training revealed several
significant differences in baseline measures. More specifically, those who
improved from MM training had worse mental health prior to randomization than
those who did not respond. The mental health measures that were different
between responders and non-responders at baseline were the PANAS-negative,
NEO-neuroticism, SF-36 Energy and Fatigue, and the SF-36 Mental Health
Component, the latter being assessed at a later visit and was also used to define
a responder. Machine learning using decision tree analysis to predict whether or
not participant’s mental health would improve following MM training had limited
ability to correctly classify a participant as a responder or non-responder, with
accuracy rates below 70% for almost all of the analyses and often below 60%,
little better than a coin flip. The baseline measures that did appear in the decision
tree classifiers were the ones already mentioned that were different at baseline
using univariate statistics. The only other measures that occasionally appeared in
the classifiers were the Life Event and expectancy measures. Mindfulness (nonjudgmental), PANAS-positive, sleep quality, and self-efficacy were not useful at
differentiating responder status. None of the demographic predictors including
age, income, and gender were useful and they did not enter into the decision
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trees. Additionally, none of these latter measures were significantly different in
responder and non-responder groups using conventional biostatistics (all p’s
greater than 0.2) and at least one other study also found no relationship of
outcomes to baseline demographic factors [289]. Besides the present study
showing that those with the lower mental health improve more from a meditation
intervention, other studies have also observed that those with worse mental
health at baseline are more likely to demonstrate improvements from a
meditation intervention [284, 285]. The fact that those who responded to the
intervention had greater fatigue at baseline is of interest. It was previously shown
that the SF-36 Energy and Fatigue subscore was sensitive to a mind-body
intervention in two randomized controlled trials of 6 months of yoga compared to
control, one in a group of 69 people with multiple sclerosis [288] and one in a
group of 135 healthy older adults.[242].

Expectancy has an impact on many outcomes, especially on self-rated outcomes
[115, 267]. Having only a wait-list control implies that some benefit of MM
compared to wait-wait-list in this, or any study, may be related to placebo effects
[115]. If this were the case, there would be two types of response to the MM
intervention confounding the analysis, i.e., placebo responsiveness predicted by
certain variables such as expectancy and responsiveness to the MM intervention
predicted by other variables such as mental health. Regarding expectancy
effects among patient with cancer being randomized to meditation or one of two
other intervention groups, the mindfulness intervention was the most preferred
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program [291]. However, those randomized to their preferred intervention
improved more over time on quality of life regardless of actual intervention type.
Women with greater psychological morbidity at baseline showed greater
improvement in stress symptoms and quality of life if they received their preferred
vs non-preferred program [291]

There were several limitations to this study. From a machine learning
perspective, the number of observations (participants) is small. To potentially
ameliorate this concern, the analysis was limited to nine predictors so that there
would be 10 observations per variable in the training set. Decision tree analysis
might have slightly benefited from methods such as ensemble learning or
AdaBoost methods [298]. Additionally, decision tree analysis may not be the best
machine learning approach for this type of data [299]. Also, adding costs of
allocation and misallocation to the decision analysis might make the analysis
more interpretable but at this level of classification accuracy it was not felt to be
worthwhile.

A more general issue with predictor analysis in clinical trials is that responder
status is in part related to regression to the mean especially since many of the
predictor variables are correlated to the SF-36 MHC score. Thus, those with
lower SF-36 MHC will be more likely to improve and many of the self-rated
predictors correlate with the SF-36 MHC (e.g., SF-36 energy, NEO-neuroticism,
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PANAS-neg). One prior study did suggest that regression to the mean is not the
only issue .[113] as well as additional data from the dissertation study.
Participants in the wait-list control arm of this dissertation study had no major
changes in their measures of stress and negative affect during the wait-list period
(Visit 1 to Visit 2) also suggesting that regression to the mean is not the only
issue. An additional limitation of the study is the lack of variability in the study
sample demographics consisting of mostly highly educated women in a relatively
narrow age range (50-85 years old) may limit both the quantitative analysis as
well as the generalizability. The prevalence of women is common in mind-body
intervention studies. Broader inclusion criteria for the next study would be helpful.

Even though simple univariate statistics demonstrated some differences in
baseline measures between responders and non-responders, achieving a useful
classification accuracy using decision tree analysis was not achieved. Improving
the classification using other statistical or machine learning approaches or adding
other predictor variables will be a useful future direction. This could potentially
help assess interactions of the variables that may need to be better captured.
Machine learning is a broad field [300, 301] and other machine techniques may
be better than decision tree analysis for this data Khondoker, 2013 #6282}.
Additionally, it is likely that these particular predictor variables were not capturing
important dynamic properties of a person that might relate to responsiveness to
an MM intervention. Stress reactivity rather than simply perceived stress or
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mental health reflecting traits over some time may better capture the stress
reactivity that one is taught to decrease in the non-judgmental aspect of
mindfulness meditation training. These characteristics may need to be captured
by more prolonged assessments using ecological momentary assessment, or
assessing stress reactivity using experimental stressors in a lab setting.

In summary, maintaining cognitive health with aging is an important public health
issue given the incidence of age-related cognitive decline as well as it being of
personal concern to most adults. Stress is known to effect cognitive health at
least in situations deviating from the population average such as major
depression, post-traumatic stress disorders, and neuroticism. It is unclear if
milder mental health problems - the target in this study - actually produce
significant cognitive changes, and it is unclear if a stress- reducing intervention in
such people who may be functioning close to their maximal level of performance
would be of any benefit to their cognitive health. However, the study did
demonstrate that self-rated mental health significantly improved from a MM
intervention in mildly stressed older adults, adding another population to the
evidence basis for MM.

There are a number of future research directions that were pointed to by this
study. One future research direction having a clinical implication is to define the
threshold of stress a person is experiencing in order to better predict who may
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benefit from an MM intervention. Another future research direction is to optimize
the intervention itself. The MM training sessions in this study were one-on-one
sessions adapted from the widely used and standardized Mindfulness-Based
Cognitive Therapy. It is possible that making the intervention more easily
available and potentially individually tailored by converting it to an internet
delivery would be better.
More importantly regarding the intervention itself, another future research
direction will be to focus the intervention to foster non-reactivity to events. MM
has two main components: focusing attention to the current moment and being
non-judgmental. The non-judgmental component is essentially decreasing stress
reactivity and an MM intervention focused on that aspect may be preferred. The
other MM component, attention to the current moment may not decrease stress
reactivity. For example, someone with PTSD who focuses on the experience of
an increased heart rate or sense of stress when around some external
environmental trigger will not experience improved clinical symptoms and may
simply self-reinforce their being trapped in a non-optimal attractor basin. An
additional research direction regarding the intervention itself would be to develop
more objective markers for meditation quality, specifically the attention to the
current moment or the non-judgmental/ non-reactivity to stressors. While there
were clear and significant MM benefits in this study on self-rated measures
related to affect, stress, and mental health, it is still unclear how these changes
would translate into physiological effects. Thus, another future direction for
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understanding the benefits of a stress-reducing intervention such as MM would
be to develop better physiological markers for stress, in particular to capture the
dynamics of the person’s response to stress, i.e., their resilience to stress. This
could include ecological momentary assessment over longer time periods to gain
a better understanding of the variability of the stress markers. Another approach
to better understanding resilience to stress would be to utilize an experimental
stressor in the lab setting. Finally, a less well-defined but always present future
research direction is the development of better models and better quantitative
analysis approaches to the multivariate but dynamically limited human empirical
data that can be practically collected.

132
REFERENCES
[1] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et
al. Prevalence of dementia in the United States: the aging, demographics, and
memory study. Neuroepidemiology. 2007;29:125-32.
[2] Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of
dementia in the United States. N Engl J Med. 2013;368:1326-34.
[3] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et
al. Prevalence of cognitive impairment without dementia in the United States.
Annals of internal medicine. 2008;148:427-34.
[4] Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, et al.
NIH state-of-the-science conference statement: Preventing Alzheimer's disease
and cognitive decline. NIH Consens State Sci Statements. 2010;27:1-30.
[5] Brookmeyer R, Grai S, Kawas C. Potential effects on prevalence of
interventions to delay onset of Alzheimer's disease. American journal of public
health. 1998;88:1337-442.
[6] Steffens DC, Potter GG. Geriatric depression and cognitive impairment.
Psychological medicine. 2008;38:163-75.
[7] Panel. AGSBCUE. American Geriatrics Society updated Beers Criteria for
potentially inappropriate medication use in older adults. J Am Geriatr Soc.
2012;60:616-31.

133
[8] Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM,
et al. Predictors of cognitive dysfunction after major noncardiac surgery.
Anesthesiology. 2008;108:18-30.
[9] NPR, Foundation RWJ, Health HSoP. The Burden of Stress in America.
http://www.rwjf.org/content/dam/farm/reports/surveys_and_polls/2014/rwjf414295
; 2014.
[10] Lupien SJ, Ouellet-Morin I, Trepanier L, Juster RP, Marin MF, Francois N, et
al. The DeStress for Success Program: effects of a stress education program on
cortisol levels and depressive symptomatology in adolescents making the
transition to high school. Neuroscience. 2013;249:74-87.
[11] Bairey Merz CN, Dwyer J, Nordstrom CK, Walton KG, Salerno JW,
Schneider RH. Psychosocial stress and cardiovascular disease:
pathophysiological links. Behav Med. 2002;27:141-7.
[12] Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular
disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248-61.
[13] Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. A
path model of chronic stress, the metabolic syndrome, and coronary heart
disease. Psychosom Med. 2002;64:418-35.
[14] Lupien SL, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout
the lifespan on the brain, behavior and cognition. Nature Reviews Neuroscience.
2009;10:434-45.

134
[15] Jallon P, Zifkin BG. Seizure Precipitants. In: Engel J, Pedley TA, editors.
Epilepsy: A comprehensive textbook, Philadelphia: Lippincott WIlliams & WIlkins;
2008. p. 77.
[16] Smith AD, Castro SL, Zigmond MJ. Stress-induced Parkinson's disease: a
working hypothesis. Physiol Behav. 2002;77:527-31.
[17] Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson's
disease. Experimental neurology. 2012;233:79-86.
[18] Macht M, Brandstetter S, Ellgring H. Stress affects hedonic responses but
not reaching-grasping in Parkinson's disease. Behavioural brain research.
2007;177:171-4.
[19] Burns MN, Nawacki E, Kwasny MJ, Pelletier D, Mohr DC. Do positive or
negative stressful events predict the development of new brain lesions in people
with multiple sclerosis? Psychological medicine. 2014;44:349-59.
[20] Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD.
Relationship between stress and relapse in multiple sclerosis: Part I. Important
features. Multiple sclerosis. 2006;12:453-64.
[21] Cleck JN, Blendy JA. Making a bad thing worse: adverse effects of stress on
drug addiction. The Journal of clinical investigation. 2008;118:454-61.
[22] Lupien SJ, Nair NPV, Briere S, Maheu F, Tu MT, Lemay M, et al. Increased
cortisol levels and impaired cognition in human aging: Implication for depression
and dementia later in life. Reviews in the Neurosciences. 1999;10:117-39.

135
[23] Sapolsky RM. Glucocorticoids, stress, and their adverse neurological effects:
relevance to aging. Experimental gerontology. 1999;34:721-32.
[24] McEwen BS. Protective and damaging effects of stress mediators. N Engl J
Med. 1998;338:171-9.
[25] Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric
disorders. Arch Gen Psychiatry. 2000;57:925-35.
[26] Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in
neurodegenerative diseases and mental disorders. Neuroendocrinology Letters.
2002;23:199-208.
[27] McEwen BS, Wingfield JC. The concept of allostasis in biology and
biomedicine. Hormones and Behavior. 2003;43:2-15.
[28] Stawski RS, Sliwinski MJ, Smyth JM. Stress-related cognitive interference
predicts cognitive function in old age. Psychology and Aging. 2006;21:535-44.
[29] Lupien SJ, Fiocco A, Wan N, Maheu E, Lord C, Schramek T, et al. Stress
hormones and human memory function across the lifespan.
psychoneuroendocrinology. 2005;30:225-42.
[30] Oken BS, Fonareva I, Wahbeh H. Stress-related cognitive dysfunction in
dementia caregivers. Journal of Geriatric Psychiatry and Neurology.
2011;24:192-9.
[31] Harvey PD, Reichenberg A, Bowie CR. Cognition and aging in
psychopathology: focus on schizophrenia and depression. Annual review of
clinical psychology. 2006;2:389-409.

136
[32] Pieper S, Brosschot JF, van der Leeden R, Thayer JF. Cardiac effects of
momentary assessed worry episodes and stressful events. Psychosom Med.
2007;69:901-9.
[33] Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression.
New York, N.Y.: Guilfor Press; 1979.
[34] Barlow DH, Ellard KK, Sauer-Zavala S, Bullis JR, Carl JR. The origins of
neuroticism. Perspectives on Psychological Science. 2014;9:481-196.
[35] Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the
environment: the case of the serotonin transporter gene and its implications for
studying complex diseases and traits. The American journal of psychiatry.
2010;167:509-27.
[36] Lahey BB. Public health significance of neuroticism. The American
psychologist. 2009;64:241-56.
[37] Wilson RS, Begeny CT, Boyle PA, Schneider JA, Bennett DA. Vulnerability
to stress, anxiety, and development of dementia in old age. Am J Geriatr
Psychiatry. 2011;19:327-34.
[38] Wilson RS, Evans DA, Bienias JL, Mendes De Leon CF, Schneider JA,
Bennett DA. Proneness to psychological distress is associated with risk of
Alzheimer's disease. Neurology. 2003;61:1479-85.
[39] Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress,
age-related neuropathology, and late-life dementia. Psychosom Med.
2007;69:47-53.

137
[40] DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for
depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci.
2008;9:788-96.
[41] Davidson RJ, McEwen BS. Social influences on neuroplasticity: stress and
interventions to promote well-being. Nat Neurosci. 2012;15:689-95.
[42] Oken B, Miller M, Goodrich E, Wahbeh H. Effects of mindfulness meditation
on self-rated stress-related measures: improvements in neuroticism and
ecological momentary assessment of stress. The Journal of Alternative and
Complementary Medicine. 2014;20:A64.
[43] Kremen WS, Lachman ME, Pruessner JC, Sliwinski M, Wilson RS.
Mechanisms of age-related cognitive change and targets for intervention: social
interactions and stress. J Gerontol A Biol Sci Med Sci. 2012;67:760-5.
[44] Holling CS. Resilience and Stability of Ecological Systems. Annu Rev Ecol
Syst. 1973;4:1-23.
[45] Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ. Neurobiology of
resilience. Nat Neurosci. 2012;15:1475-84.
[46] Davidson RJ. Affective style, psychopathology, and resilience: brain
mechanisms and plasticity. The American psychologist. 2000;55:1196-214.
[47] Adams RE, Boscarino JA. Predictors of PTSD and delayed PTSD after
disaster: the impact of exposure and psychosocial resources. The Journal of
nervous and mental disease. 2006;194:485-93.

138
[48] McFarlane AC. The long-term costs of traumatic stress: intertwined physical
and psychological consequences. World psychiatry : official journal of the World
Psychiatric Association. 2010;9:3-10.
[49] Yehuda R. Post-traumatic stress disorder. N Engl J Med. 2002;346:108-14.
[50] Engelhard IM, van den Hout MA, Schouten EG. Neuroticism and low
educational level predict the risk of posttraumatic stress disorder in women after
miscarriage or stillbirth. Gen Hosp Psychiatry. 2006;28:414-7.
[51] Harmell AL, Chattillion EA, Roepke SK, Mausbach BT. A review of the
psychobiology of dementia caregiving: a focus on resilience factors. Current
psychiatry reports. 2011;13:219-24.
[52] Stern Y. What is cognitive reserve? Theory and research application of the
reserve concept. Journal of the International Neuropsychological Society : JINS.
2002;8:448-60.
[53] Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, et al.
Factors associated with resistance to dementia despite high Alzheimer disease
pathology. Neurology. 2009;72:354-60.
[54] Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, et al. Neural
compensation in older people with brain amyloid-beta deposition. Nat Neurosci.
2014.
[55] Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, et
al. Trajectory of white matter hyperintensity burden preceding mild cognitive
impairment. Neurology. 2012;79:741-7.

139
[56] DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, et al. The
effect of white matter hyperintensity volume on brain structure, cognitive
performance, and cerebral metabolism of glucose in 51 healthy adults.
Neurology. 1995;45:2077-84.
[57] Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, BarroetaEspar I, et al. Dissecting phenotypic traits linked to human resilience to
Alzheimer's pathology. Brain. 2013;136:2510-26.
[58] Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a
theoretical integration and synthesis of laboratory research. Psychol Bull.
2004;130:355-91.
[59] de Brouwer SJ, Kraaimaat FW, Sweep FC, Creemers MC, Radstake TR,
van Laarhoven AI, et al. Experimental stress in inflammatory rheumatic diseases:
a review of psychophysiological stress responses. Arthritis research & therapy.
2010;12:R89.
[60] van Marle HJ, Hermans EJ, Qin S, Fernandez G. Enhanced resting-state
connectivity of amygdala in the immediate aftermath of acute psychological
stress. Neuroimage. 2010;53:348-54.
[61] Schultz DH, Balderston NL, Helmstetter FJ. Resting-state connectivity of the
amygdala is altered following Pavlovian fear conditioning. Frontiers in human
neuroscience. 2012;6:242.

140
[62] Veer IM, Oei NY, Spinhoven P, van Buchem MA, Elzinga BM, Rombouts SA.
Beyond acute social stress: increased functional connectivity between amygdala
and cortical midline structures. Neuroimage. 2011;57:1534-41.
[63] Vaisvaser S, Lin T, Admon R, Podlipsky I, Greenman Y, Stern N, et al.
Neural traces of stress: cortisol related sustained enhancement of amygdalahippocampal functional connectivity. Frontiers in human neuroscience.
2013;7:313.
[64] Lederbogen F, Kirsch P, Haddad L, Streit F, Tost H, Schuch P, et al. City
living and urban upbringing affect neural social stress processing in humans.
Nature. 2011;474:498-501.
[65] Mattson MP. Hormesis defined. Ageing Res Rev. 2008;7:1-7.
[66] Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, et al.
Biological stress response terminology: Integrating the concepts of adaptive
response and preconditioning stress within a hormetic dose-response framework.
Toxicol Appl Pharmacol. 2007;222:122-8.
[67] Rimmele U, Zellweger BC, Marti B, Seiler R, Mohiyeddini C, Ehlert U, et al.
Trained men show lower cortisol, heart rate and psychological responses to
psychosocial stress compared with untrained men. Psychoneuroendocrinology.
2007;32:627-35.
[68] Masoro EJ. Role of hormesis in life extension by caloric restriction. Doseresponse : a publication of International Hormesis Society. 2007;5:163-73.

141
[69] Gaab J, Blattler N, Menzi T, Pabst B, Stoyer S, Ehlert U. Randomized
controlled evaluation of the effects of cognitive-behavioral stress management on
cortisol responses to acute stress in healthy subjects.
Psychoneuroendocrinology. 2003;28:767-79.
[70] de Brouwer SJ, Kraaimaat FW, Sweep FC, Donders RT, Eijsbouts A, van
Koulil S, et al. Psychophysiological responses to stress after stress management
training in patients with rheumatoid arthritis. PLoS One. 2011;6:e27432.
[71] Barnes PM, Bloom B. Complementary and alternative medicine use among
adults and children: United States, 2007. National Health Statistics Reports2008.
p. 1-24.
[72] Barrows KA, Jacobs BP. Mind-body medicine. An introduction and review of
the literature. Med Clin North Am. 2002;86:11-31.
[73] Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: state of
the science, implications for practice. Journal of the American Board of Family
Practice. 2003;16:131-47.
[74] Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and
monitoring in meditation. Trends Cogn Sci. 2008;12:163-9.
[75] Kabat-Zinn J, Lipworth L, Burney R, Sellers W. Four-year follow-up of a
meditation-based program for the self-regulation of chronic pain: treatment
outcomes and compliance. Clinical Journal of Pain. 1987;2:159-73.

142
[76] Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain
patients based on the practice of mindfulness meditation: theoretical
considerations and preliminary results. Gen Hosp Psychiatry. 1982;4:33-47.
[77] Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list
controlled clinical trial: the effect of a mindfulness meditation-based stress
reduction program on mood and symptoms of stress in cancer outpatients.
Psychosomatic Medicine. 2000;62:613-22.
[78] Chiesa A, Serretti A. A systematic review of neurobiological and clinical
features of mindfulness meditations. Psychological Medicine. 2010;40:1239-52.
[79] Kabat-Zinn J, Massion A, Kristeller J, Peterson L, Fletcher KE, Pbert L, et al.
Effectiveness of a meditation-based stress-reduction program in the treatment of
anxiety disorders. American Journal of Psychiatry. 1992;149:936-43.
[80] Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive
abilities? a systematic review of neuropsychoogical findings. Clinical Psychology
Review. 2011;32:449-64.
[81] Elkins G, Fisher W, Johnson A. Mind-body therapies in integrative oncology.
Curr Treat Options Oncol. 2010;11:128-40.
[82] Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress
reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57:3543.

143
[83] Zeidan F, Grant JA, Brown CA, McHaffie JG, Coghill RC. Mindfulness
meditation-related pain relief: evidence for unique brain mechanisms in the
regulation of pain. Neurosci Lett. 2012;520:165-73.
[84] Ospina MB, Bond K, Karkhaneh M, al e. Meditation practices for health:
state of the research (AHRQ). Evid Rep Technol Assess (Full Rep). 2007;
Number 155, Publication No. 07-E010.:1-263.
[85] Wahbeh H, Elsas S-M, Oken B. Mind-body interventions: applications in
neurology. Neurology. 2008;70:2321-8.
[86] Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R,
et al. Meditation programs for psychological stress and well-being: a systematic
review and meta-analysis. JAMA internal medicine. 2014;174:357-68.
[87] Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, et al.
Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev.
2013;33:763-71.
[88] Baer RA, Smith GT, Hopkins J, Krietmeyer J, Toney L. Using self-report
assessment methods to explore facets of mindfulness. Assessment. 2006;13:2745.
[89] Tran US, Gluck TM, Nader IW. Investigating the Five Facet Mindfulness
Questionnaire (FFMQ): construction of a short form and evidence of a two-factor
higher order structure of mindfulness. J Clin Psychol. 2013;69:951-65.
[90] Wahbeh H, Lu M, Oken B. Mindful awareness and non-judging in relation to
posttraumatic stress disorder symptoms. Mindfulness (N Y). 2011;2:219-27.

144
[91] Chesney MA, Darbes LA, Hoerster K, Taylor JM, Chambers DB, Anderson
DE. Positive emotions: exploring the other hemisphere in behavioral medicine.
Int J Behav Med. 2005;12:50-8.
[92] Hofmann SG, Grossman P, Hinton DE. Loving-kindness and compassion
meditation: potential for psychological interventions. Clin Psychol Rev.
2011;31:1126-32.
[93] Mohan A, Sharma R, Bijlani RL. Effect of meditation on stress-induced
changes in cognitive functions. J Altern Complement Med. 2011;17:207-12.
[94] Pace TW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD, et al. Effect of
compassion meditation on neuroendocrine, innate immune and behavioral
responses to psychosocial stress. Psychoneuroendocrinology. 2009;34:87-98.
[95] Kemeny ME, Foltz C, Cavanagh JF, Cullen M, Giese-Davis J, Jennings P, et
al. Contemplative/emotion training reduces negative emotional behavior and
promotes prosocial responses. Emotion. 2012;12:338-50.
[96] Goleman DJ, Schwartz GE. Meditation as an intervention in stress reactivity.
J Consult Clin Psychol. 1976;44:456-66.
[97] Marciniak R, Sheardova K, Cermakova P, Hudecek D, Sumec R, Hort J.
Effect of meditation on cognitive functions in context of aging and
neurodegenerative diseases. Frontiers in behavioral neuroscience. 2014;8:17.
[98] Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive
abilities? A systematic review of neuropsychological findings. Clin Psychol Rev.
2011;31:449-64.

145
[99] Semple RJ. Does mindfulness meditation enhance attention? a randomized
contrlled trial. Mindfulness. 2010;1:121-30.
[100] Moore A, Gruber T, Derose J, Malinowski P. Regular, brief mindfulness
meditation practice improves electrophysiological markers of attentional control.
Frontiers in human neuroscience. 2012;6:18.
[101] Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies
subsystems of attention. Cogn Affect Behav Neurosci. 2007;7:109-19.
[102] Tang YY, Ma Y, Wang J, Fan Y, Feng S, Lu Q, et al. Short-term meditation
training improves attention and self-regulation. Proc Natl Acad Sci U S A.
2007;104:17152-6.
[103] Zeidan F, Johnson SK, Diamond BJ, David Z, Goolkasian P. Mindfulness
meditation improves cognition: evidence of brief mental training. Conscious
Cogn. 2010;19:597-605.
[104] Jha AP, Stanley EA, Kiyonaga A, Wong L, Gelfand L. Examining the
protective effects of mindfulness training on working memory capacity and
affective experience. Emotion. 2010;10:54-64.
[105] Kaul P, Passafiume J, Sargent CR, O'Hara BF. Meditation acutely improves
psychomotor vigilance, and may decrease sleep need. Behavioral and brain
functions : BBF. 2010;6:47.
[106] Gard T, Holzel BK, Lazar SW. The potential effects of meditation on agerelated cognitive decline: a systematic review. Annals of the New York Academy
of Sciences. 2014;1307:89-103.

146
[107] Oken BS, Fonareva I, Haas M, Wahbeh H, Lane JB, Zajdel DP, et al. Pilot
controlled trial of mindfulness meditation and education for dementia caregivers.
Journal of Alternative and Complementary Medicine. 2010;16:1031-8.
[108] Golden CJ. Stroop Color and Word Test Manual. Wood Dale, IL: Stoelting
Co.; 2002.
[109] Fox KC, Nijeboer S, Dixon ML, Floman JL, Ellamil M, Rumak SP, et al. Is
meditation associated with altered brain structure? A systematic review and
meta-analysis of morphometric neuroimaging in meditation practitioners.
Neurosci Biobehav Rev. 2014;43:48-73.
[110] Cahn BR, Polich J. Meditation states and traits. EEG, ERP, and
neuroimaging studies. Psychological Bulletin. 2006;132:180-211.
[111] Ahani A, Wahbeh H, Nezamfar H, Miller M, Erdogmus D, Oken B.
Quantitative change of EEG and respiration signals during mindfulness
meditation. Journal of neuroengineering and rehabilitation. 2014;11:87.
[112] Lutz A, Slagter HA, Rawlings NB, Francis AD, Greischar LL, Davidson RJ.
Mental training enhances attentional stability: neural and behavioral evidence. J
Neurosci. 2009;29:13418-27.
[113] Kim B, Cho SJ, Lee KS, Lee JY, Choe AY, Lee JE, et al. Factors
associated with treatment outcomes in mindfulness-based cognitive therapy for
panic disorder. Yonsei medical journal. 2013;54:1454-62.
[114] McDonald CJ, Mazzuca SA. How much of the placebo 'effect' is really
statistical regression? Statistics in medicine. 1983;2:417-27.

147
[115] Oken B. Placebo effects: clinical aspects and neurobiology. Brain.
2008;131:2812-23.
[116] Wahbeh H, Zwickey H, Oken B. One method for objective adherence
measurement in mind-body medicine. The Journal of Alternative and
Complementary Medicine. 2011;17:1-3.
[117] Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout
the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci.
2009;10:434-45.
[118] Novakova B, Harris PR, Ponnusamy A, Reuber M. The role of stress as a
trigger for epileptic seizures: a narrative review of evidence from human and
animal studies. Epilepsia. 2013;54:1866-76.
[119] Mobus GE, Kalton MC. Principles of Systems Science: Springer; 2015.
[120] Ader R. Psychoneuroimmunology. 4th ed. San Diego: Elsevier Academic
Press; 2007.
[121] McEwen BS. Protection and damage from acute and chronic stress:
allostasis and allostatic overload and relevance to the pathophysiology of
psychiatric disorders. Annals of the New York Academy of Sciences.
2004;1032:1-7.
[122] Vaseghi M, Shivkumar K. The role of the autonomic nervous system in
sudden cardiac death. Progress in cardiovascular diseases. 2008;50:404-19.
[123] Johns LE, Aiello AE, Cheng C, Galea S, Koenen KC, Uddin M.
Neighborhood social cohesion and posttraumatic stress disorder in a community-

148
based sample: findings from the Detroit Neighborhood Health Study. Social
psychiatry and psychiatric epidemiology. 2012;47:1899-906.
[124] Kemeny ME. Psychobiological responses to social threat: evolution of a
psychological model in psychoneuroimmunology. Brain Behav Immun.
2009;23:1-9.
[125] Young M, Schieman S. When hard times take a toll: the distressing
consequences of economic hardship and life events within the family-work
interface. Journal of health and social behavior. 2012;53:84-98.
[126] Harrell JP, Hall S, Taliaferro J. Physiological responses to racism and
discrimination: an assessment of the evidence. American journal of public health.
2003;93:243-8.
[127] Day TA. Defining stress as a prelude to mapping its neurocircuitry: no help
from allostasis. Progress in neuro-psychopharmacology & biological psychiatry.
2005;29:1195-200.
[128] Dohrenwend BP. Inventorying stressful life events as risk factors for
psychopathology: Toward resolution of the problem of intracategory variability.
Psychol Bull. 2006;132:477-95.
[129] Lupien S. Well Stressed: how you can manage stress before it turns toxic.
Mississauga, Ontario: Wiley; 2012.
[130] Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’—
a tool for investigating psychobiological stress responses in a laboratory setting.
Neuropsychobiology. 1993;28:76-81.

149
[131] Dedovic K, Renwick R, Mahani NK, Engert V, Lupien SJ, Pruessner JC.
The Montreal Imaging Stress Task: using functional imaging to investigate the
effects of perceiving and processing psychosocial stress in the human brain. J
Psychiatry Neurosci. 2005;30:319-25.
[132] Gianaros PJ, Derbyshire SW, May JC, Siegle GJ, Gamalo MA, Jennings
JR. Anterior cingulate activity correlates with blood pressure during stress.
Psychophysiology. 2005;42:627-35.
[133] Lovallo W. The cold pressor test and autonomic function: a review and
integration. Psychophysiology. 1975;12:268-82.
[134] Lang PJ, Bradley MM, Cuthbert BN. International affective picture system
(IAPS): Technical manual and affective ratings. Gainesville: University of Florida,
Center for Research in Psychophysiology; 1999.
[135] Berretta S. Cortico-amygdala circuits: role in the conditioned stress
response. Stress. 2005;8:221-32.
[136] McEwen BS, Lasley EN. Allostatic load: when protection gives way to
damage. Advances in mind-body medicine. 2003;19:28-33.
[137] McEwen B. The neurobiology of stress: from serendipity to clinical
relevance. Brain Res Interact. 2000;886:172-89.
[138] McEwen BS. Physiology and neurobiology of stress and adaptation: central
role of the brain. Physiological reviews. 2007;87:873-904.
[139] Joels M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci.
2009;10:459-66.

150
[140] Datson NA, Morsink MC, Meijer OC, de Kloet ER. Central corticosteroid
actions: Search for gene targets. European journal of pharmacology.
2008;583:272-89.
[141] Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD.
Accelerated telomere shortening in response to life stress. PNAS.
2004;101:17312-5.
[142] Bernston GG, Caciollo JT, Quigley KS. Autonomic determinism. the modes
of autonomic control, the doctrine of autonomic space, and the laws of autonomic
constraint. Psychological Review. 1991;98:459-87.
[143] Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R.
Psychoneuroimmunology and Psychosomatic Medicine: Back to the Future.
Psychosom Med. 2002;64:15-28.
[144] Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress.
Endocrinol Metab Clin North Am. 2001;30:695-728; vii-viii.
[145] Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress:
hormonal mediators and human development. Horm Res. 2003;59:161-79.
[146] Pruessner M, Hellhammer DH, Pruessner JC, Lupien SJ. Self-reported
depressive symptoms and stress levels in healthy young men: Associations with
the cortisol response to awakening. Psychosom Med. 2002;65:92-9.
[147] Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological
and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA
sulfate (DHEAS). Frontiers in neuroendocrinology. 2009;30:65-91.

151
[148] Noto Y, Sato T, Kudo M, Kurata K, Hirota K. The relationship between
salivary biomarkers and state-trait anxiety inventory score under mental
arithmetic stress: a pilot study. Anesthesia and analgesia. 2005;101:1873-6.
[149] Young AH, Gallagher P, Porter RJ. Elevation of the cortisoldehydroepiandrosterone ratio in drug-free depressed patients. The American
journal of psychiatry. 2002;159:1237-9.
[150] de Kloet ER. From vasotocin to stress and cognition. European journal of
pharmacology. 2010;626:18-26.
[151] Cacioppo JT, Tassinary LG, Bernston GG. Handbook of Psychophysiology.
3rd ed. New York: Cambridge University Press; 2007. p. 898.
[152] Pumprla J, Howorka K, Groves D, M C, Nolan J. Functional assessment of
heart rate variability: physiological basis and practical applications. International
journal of cardiology. 2002;84:1-14.
[153] Mukherjee S, Yadav R, Yung I, Zajdel D, Oken BS. Sensitivity to mental
effort and test-retest reliability of heart rate variability measures in healthy
seniors. Clinical Neurophysiology. 2011;122:2059-66.
[154] Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction:
Implications for health. Nature Reviews Immunology. 2005;5:243-51.
[155] Fonareva I, Oken BS. Physiological and functional consequences of
caregiving for relatives with dementia International Psychogeriatrics
2014;26:725-47.

152
[156] Tomiyama AJ, O'Donovan A, Lin J, Puterman E, Lazaro A, Chan J, et al.
Does cellular aging relate to patterns of allostasis? An examination of basal and
stress reactive HPA axis activity and telomere length. Physiol Behav.
2012;106:40-5.
[157] Schwartz MS, Andrasik F. Biofeedback: A Practitioner's Guide. 3rd ed. New
York: Guilford Press; 2003. p. 930.
[158] Dietrich M, Verdolini Abbott K. Vocal function in introverts and extraverts
during a psychological stress reactivity protocol. Journal of speech, language,
and hearing research : JSLHR. 2012;55:973-87.
[159] Arnrich B, Setz C, La Marca R, Troster G, Ehlert U. What does your chair
know about your stress level? IEEE transactions on information technology in
biomedicine : a publication of the IEEE Engineering in Medicine and Biology
Society. 2010;14:207-14.
[160] McEwen BS, Sapolsky RM. Stress and cognitive function. Current opinion
in neurobiology. 1995;5:205-16.
[161] Bremner JD. Does stress damage the brain? Biological Psychiatry.
1999;45:797-805.
[162] Gotlib IH, Joormann J. Cognition and depression: current status and future
directions. Annual review of clinical psychology. 2010;6:285-312.
[163] Arnsten AF. Stress signalling pathways that impair prefrontal cortex
structure and function. Nat Rev Neurosci. 2009;10:410-22.

153
[164] Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, et al.
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during
traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen
Psychiatry. 2004;61:168-76.
[165] Garcia R, Vouimba RM, Baudry M, Thompson RF. The amygdala
modulates prefrontal cortex activity relative to conditioned fear. Nature.
1999;402:294-6.
[166] Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, et al.
Cortisol levels during human aging predict hippocampal atrophy and memory
deficits. Nat Neurosci. 1998;1:69-73.
[167] Childress JE, McDowell EJ, Dalai VV, Bogale SR, Ramamurthy C, Jawaid
A, et al. Hippocampal volumes in patients with chronic combat-related
posttraumatic stress disorder: a systematic review. The Journal of
neuropsychiatry and clinical neurosciences. 2013;25:12-25.
[168] Woon FL, Sood S, Hedges DW. Hippocampal volume deficits associated
with exposure to psychological trauma and posttraumatic stress disorder in
adults: a meta-analysis. Progress in neuro-psychopharmacology & biological
psychiatry. 2010;34:1181-8.
[169] Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, et
al. Smaller hippocampal volume predicts pathologic vulnerability to psychological
trauma. Nat Neurosci. 2002;5:1242-7.

154
[170] Yaffe K, Vittinghoff E, Lindquist K, Barnes D, Covinsky KE, Neylan T, et al.
Posttraumatic stress disorder and risk of dementia among US veterans. Arch
Gen Psychiatry. 2010;67:608-13.
[171] Kaye J, Swihart T, Howieson D, Dame A, Moore M, Karnos T, et al. Volume
loss of the hippocampus and temporal lobe in healthy elderly destined to develop
dementia. Neurology. 1997;48:1297-134.
[172] Vermetten E, Vythilingam M, Southwick SM, Charney DS, Bremner JD.
Long-term treatment with paroxetine increases verbal declarative memory and
hippocampal volume in posttraumatic stress disorder. Biol Psychiatry.
2003;54:693-702.
[173] Anacker C, Zunszain PA, Cattaneo A, Carvalho LA, Garabedian MJ, Thuret
S, et al. Antidepressants increase human hippocampal neurogenesis by
activating the glucocorticoid receptor. Molecular psychiatry. 2011;16:738-50.
[174] Perez-Edgar K, Kujawa A, Nelson SK, Cole C, Zapp DJ. The relation
between electroencephalogram asymmetry and attention biases to threat at
baseline and under stress. Brain and cognition. 2013;82:337-43.
[175] Anokhin AP, Heath AC, Myers E. Genetic and environmental influences on
frontal EEG asymmetry: a twin study. Biol Psychol. 2006;71:289-95.
[176] Ceballos NA, Giuliano RJ, Wicha NY, Graham R. Acute stress and eventrelated potential correlates of attention to alcohol images in social drinkers.
Journal of studies on alcohol and drugs. 2012;73:761-71.

155
[177] Davidson RJ. What does the prefrontal cortex "do" in affect: perspectives
on frontal EEG asymmetry research. Biol Psychol. 2004;67:219-33.
[178] Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC. The brain
and the stress axis: the neural correlates of cortisol regulation in response to
stress. Neuroimage. 2009;47:864-71.
[179] Pruessner JC, Dedovic K, Khalili-Mahani N, Engert V, Pruessner M, Buss
C, et al. Deactivation of the limbic system during acute psychosocial stress:
evidence from positron emission tomography and functional magnetic resonance
imaging studies. Biol Psychiatry. 2008;63:234-40.
[180] Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a
marker of cumulative biological risk: MacArthur studies of successful aging.
Proceedings of the National Academy of Sciences. 2001;98:4770-5.
[181] Evans GW, Schamberg MA. Childhood poverty, chronic stress, and adult
working memory. Proceedings of the National Academy of Sciences.
2009;106:6545-9.
[182] Bellingrath S, Weigl T, Kudielka BM. Chronic work stress and exhaustion is
associated with higher alostatic load in female school teachers. Stress.
2009;12:37-48.
[183] Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic
stress and impact on health and cognition. Neurosci Biobehav Rev.
2009;doi:10.1016/neubiorev.2009.10.002.

156
[184] Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, et al. Early
consumption of peanuts in infancy is associated with a low prevalence of peanut
allergy. The Journal of allergy and clinical immunology. 2008;122:984-91.
[185] Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, et al. Increased
cortisol levels and impaired cognition in human aging: implication for depression
and dementia in later life. Rev Neurosci. 1999;10:117-39.
[186] Spielberger C, Gorsuch R, Lushene R. The state trait anxiety inventory
(STAI) test manual. Palo Alto, CA: Consulting Psychologists Press; 1983.
[187] Andrews J, Ali N, Pruessner JC. Reflections on the interaction of
psychogenic stress systems in humans: the stress coherence/compensation
model. Psychoneuroendocrinology. 2013;38:947-61.
[188] Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system
mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.
Progress in neuro-psychopharmacology & biological psychiatry. 2005;29:120113.
[189] Oken BS, Salinsky MC, Elsas SM. Vigilance, alertness, or sustained
attention: Physiological basis and measurement. Clinical Neurophysiology.
2006;117:1885-901.
[190] Aston-Jones G, Cohen JD. An integrative theory of locus coeruleusnorepinephrine function: adaptive gain and optimal performance. Annual review
of neuroscience. 2005;28:403-50.

157
[191] Engert V, Vogel S, Efanov SI, Duchesne A, Corbo V, Ali N, et al.
Investigation into the cross-correlation of salivary cortisol and alpha-amylase
responses to psychological stress. Psychoneuroendocrinology. 2011;36:1294302.
[192] Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al.
Influence of life stress on depression: Moderation by a polymorphism in the 5HTT Gene. Science. 2003;l301:386-9.
[193] Dodge HH, Mattek NC, Austin D, Hayes TL, Kaye JA. In-home walking
speeds and variability trajectories associated with mild cognitive impairment.
Neurology. 2012;78:1946-52.
[194] Csikszentmihalyi M, Larson R. Validity and reliability of the ExperienceSampling Method. The Journal of nervous and mental disease. 1987;175:526-36.
[195] Conner TS, Barrett LF. Trends in ambulatory self-report: the role of
momentary experience in psychosomatic medicine. Psychosom Med.
2012;74:327-37.
[196] Yamaguchi S, Hale LA, D'Esposito M, Knight RT. Rapid prefrontalhippocampal habituation to novel events. J Neurosci. 2004;24:5356-63.
[197] Gati I, Ben-Shakhar G. Novelty and significance in orientation and
habituation: a feature-matching approach. Journal of experimental psychology
General. 1990;119:251-63.
[198] Petersen SE, Posner MI. The attention system of the human brain: 20
years after. Annual review of neuroscience. 2012;35:73-89.

158
[199] Squire LR, Wixted JT. The cognitive neuroscience of human memory since
H.M. Annual review of neuroscience. 2011;34:259-88.
[200] Hermans EJ, Battaglia FP, Atsak P, de Voogd LD, Fernandez G,
Roozendaal B. How the amygdala affects emotional memory by altering brain
network properties. Neurobiol Learn Mem. 2014;112:2-16.
[201] Debiec J, Ledoux JE. Disruption of reconsolidation but not consolidation of
auditory fear conditioning by noradrenergic blockade in the amygdala.
Neuroscience. 2004;129:267-72.
[202] Costa PT, McCrae RR. NEO Inventories: Professional manual. Lutz, FL:
Psychological Assessment Resources, Inc; 2010.
[203] Rasmussen HN, Scheier MF, Greenhouse JB. Optimism and physical
health: a meta-analytic review. Annals of behavioral medicine : a publication of
the Society of Behavioral Medicine. 2009;37:239-56.
[204] Cotton S, Zebracki K, Rosenthal SL, Tsevat J, Drotar D. Religion/spirituality
and adolescent health outcomes: a review. The Journal of adolescent health :
official publication of the Society for Adolescent Medicine. 2006;38:472-80.
[205] Benedetti F. The Importance of Considering the Effects of Perceived Group
Assignment in Placebo-Controlled Trials. Eval Health Prof. 2005;28:5-6.
[206] Oken B, Flegal K, Zajdel D, Kishiyama S, Haas M, Peters D. Expectancy
effect: impact of pill administration on cognitive performance in healthy seniors.
Journal of Clinical and Experimental Neuropsychology. 2008;30:7-17.

159
[207] Johansen O, Brox J, Flaten MA. Placebo and Nocebo responses, cortisol,
and circulating beta-endorphin. Psychosom Med. 2003;65:786-90.
[208] Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious
Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal
Placebo/Nocebo Responses. J Neurosci. 2003;23:4315-23.
[209] Friedman AK, Walsh JJ, Juarez B, Ku SM, Chaudhury D, Wang J, et al.
Enhancing depression mechanisms in midbrain dopamine neurons achieves
homeostatic resilience. Science. 2014;344:313-9.
[210] de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to
disease. Nat Rev Neurosci. 2005;6:463-75.
[211] Wahbeh H, Oken B, Lu M. Differences in veterans with and without
posttraumatic stress disorder during relaxing and stressful condition. Annual
Meeting American Psychosomatic Society 2010, A61; 2010.
[212] Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA.
Intensive meditation training, immune cell telomerase activity, and psychological
mediators. Psychoneuroendocrinology. 2011;36:664-81.
[213] Davidson R, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D,
Santorelli S, et al. Alterations in Brain and Immune Function Produced by
Mindfulness Meditation. Psychosomatic Medicine. 2003;65.
[214] Tang YY, Ma Y, Wang J, Fan Y, Feng S, ea. Short-term meditation training
improves attention and self-regulation. PNAS. 2007;104:17152-6.

160
[215] Oken BS, Fonareva I, Haas M, Wahbeh H, Lane JB, Zajdel D, et al. Pilot
controlled trial of mindfulness meditation and education for dementia caregivers.
J Altern Complement Med. 2010;16:1031-8.
[216] Jung Y-H, Kang D-H, Jang JH, Park HY, Byun MS, Kwon SJ, et al. The
effects of mind-body training on stress reduction, positive affect, and plasma
catecholamines. Neuroscience Letters. 2010;479:138-42.
[217] Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S, et al. Central and
autonomic nervous system interaction is altered by short-term meditation. Proc
Natl Acad Sci U S A. 2009;106:8865-70.
[218] Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for
improvement in mindfulness-based stress reduction. Complement Ther Clin
Pract. 2010;16:13-9.
[219] Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu
R, Mathews HL. Effect of mindfulness based stress reduction on immune
function, quality of life and coping in women newly diagnosed with early stage
breast cancer. Brain Behav Immun. 2008;22:969-81.
[220] Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress
reduction in relation to quality of life, mood, symptoms of stress and levels of
cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and
prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448-74.

161
[221] Tang YY, Lu Q, Geng X, Stein EA, Yang Y, Posner MI. Short-term
meditation induces white matter changes in the anterior cingulate. Proc Natl
Acad Sci U S A. 2010;107:15649-52.
[222] Holzel BK, Carmody J, Vangel M, Congleton C, Yerramsetti SM, Gard T, et
al. Mindfulness practice leads to increases in regional brain gray matter density.
Psychiatry research. 2011;191:36-43.
[223] Weng HY, Fox AS, Shackman AJ, Stodola DE, Caldwell JZ, Olson MC, et
al. Compassion training alters altruism and neural responses to suffering.
Psychological science. 2013;24:1171-80.
[224] Oken BS, Chamine I, Wakeland W. A systems approach to stress,
stressors, and resilience in humans. Behavioural Neuroscience. 2015;282:14454.
[225] Abbott RA, Whear R, Rodgers LR, Bethel A, Thompson Coon J, Kuyken W,
et al. Effectiveness of mindfulness-based stress reduction and mindfulness
based cognitive therapy in vascular disease: A systematic review and metaanalysis of randomised controlled trials. J Psychosom Res. 2014;76:341-51.
[226] Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies
account for most dementia cases in community-dwelling older persons.
Neurology. 2007;69:2197-204.
[227] White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, et al.
Recent clinical-pathologic research on the causes of dementia in late life: update
from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18:224-7.

162
[228] Cohen S, Karmarck T, Mermelstein R. A global measure of perceived
stress. Journal of health and social behavior. 1983;24:385-96.
[229] Knopman DS, Roberts RO, Geda YE, Pankratz VS, Christianson TJ,
Petersen RC, et al. Validation of the telephone interview for cognitive statusmodified in subjects with normal cognition, mild cognitive impairment, or
dementia. Neuroepidemiology. 2010;34:34-42.
[230] Pocock SJ, Simon R. Sequential treatment assignment with balancing for
prognostic factors in the controlled clinical trial. Biometrics. 1975;31:103-15.
[231] Wahbeh H, Lane JB, Goodrich E, Miller M, Oken BS. One-on-one
mindfulness meditation trainings in a research setting. Mindfulness. 2014;5:8899.
[232] Kabat-Zinn J. Full Catastrophe Living: Using the wisdom of your body and
mind to face stress, pain, and illness. New York: Delacourte Press; 1990.
[233] Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based Cognitive
Therapy for Depression: A new approach to preventing relapse. New York:
Guilford; 2002.
[234] Wahbeh H, Oken B. Perceived benefit from mindfulness meditation in
combat veterans with posttraumatic stress disorder. International Research
Conference on Integrative Medicine and Health. Miami, FL2014.
[235] Goodrich E, Wahbeh H, Mooney A, Miller M, Oken BS. Teaching
mindfulness meditation to adults with severe speech and physical impairments:
An exploratory study. Neuropsychol Rehabil. 2014:1-25.

163
[236] Watson D, Clark LA, Tellegen A. Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc
Psychol. 1988;54:1063-70.
[237] Radloff L. The CES-D scale: a self-report depression scale for research in
the general population. Applied Psychological Measurement. 1977;1:385-401.
[238] Leue A, Beauducel A. The PANAS structure revisited: on the validity of a
bifactor model in community and forensic samples. Psychol Assess.
2011;23:215-25.
[239] Thompson ER. Development and validation of an internationally reliable
short-form of the Positive and Negative Affect Schedule. Journal of CrossCultural Psychology. 2007;38:227-41.
[240] Ware JF. SF-36 Health Survey: Manual interpretation Guide. Boston: The
Health Institute; 1993.
[241] Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, et al.
Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology.
2004;62:2058-64.
[242] Oken BS, Zajdel D, Kishiyama S, Flegal K, Dehen C, Haas M, et al.
Randomized controlled 6-month trial of yoga in healthy seniors. Alternative
Therapies in Health and Medicine. 2006;12:40-7.
[243] Ware JE, Jr. SF-36 health survey update. Spine (Phila Pa 1976).
2000;25:3130-9.

164
[244] Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J,
Wright S, Johnston M, editors. Measures in health psychology: a user's portfolio
Causal and control beliefs, Windsor, UK: Nfer-Nelson; 1995. p. 35-7.
[245] Astin JA. Stress reduction through mindfulness meditation. Effects on
psychological symptomatology, sense of control, and spiritual experiences.
Psychother Psychosom. 1997;66:97-106.
[246] Fisher PA, Laschinger HS. A relaxation training program to increase selfefficacy for anxiety control in Alzheimer family caregivers. Holist Nurs Pract.
2001;15:47-58.
[247] Buyse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh
Sleep Quality Index: a new instrument for psychiatric practice and research.
Psychiatric Research. 1989;28:192-213.
[248] Neuendorf R, Wahbeh H, Chaime I, Yu J, Hutshison K, Oken BS. The
Effects of Mind-Body Interventions on Sleep Quality: A Systematic Review.
Evidence-Based Complementary and Alternative Medicine. 2015.
[249] Oken BS, Fonareva I, Wahbeh H. Stress-related cognitive dysfunction in
dementia caregivers. Journal of Geriatric Psychiatry and Neurology.
2011;24:192-9.
[250] Devilly GJ, Borkovec TD. Psychometric properties of the
credibility/expectancy questionnaire. Journal of Behavioral Therapy and
Experimental Psychiatry. 2000;31:73-86.

165
[251] Oken BS, Flegal K, Zajdel D, Kishiyama S, Haas M, Peters D. Expectancy
effect: impact of pill administration on cognitive performance in healthy seniors.
Journal of Clinical and Experimental Neuropsychology. 2008;30:7-17.
[252] Cherkin D, Deyo RA, Berg AO. Evaluation of a physician intervention to
improve primary care for low-back pain: II. Impact on patients. Spine.
1991;16:1173-8.
[253] Perret E. The left frontal lobe of man and the suppression of habitual
responses in verbal categorical behavior. Neuropsychologia. 1974;12:323-30.
[254] Schmidt M. Rey Auditory-Verbal Learning Test. Los Angeles: Western
Psychological Services; 1996.
[255] Benton A, Hamsher K. Multilingual Aphasia Examination. Iowa City, Iowa:
AJA Associates; 1989.
[256] Wechsler D. Wechsler Adult Intelligence Scale - Fourth Edition. San
Antonio, TX: Pearson; 2008.
[257] Task Force of the European Society of Cardiology N. Heart rate variability standards of measurement, physiological interpretation, and clinical use.
Circulation. 1996;93:1043-65.
[258] Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of
generalized anxiety disorder and worry. Biological Psychiatry. 1996;39:255-66.
[259] Wahbeh H, Oken B. Salivary cortisol lower in posttraumatic stress disorder.
Journal of Traumatic Stress. 2013;26:1-8.

166
[260] Kraemer HC, Giese-Davis J, Yutsis M, O'Hara R, Neri E, GallagherThompson D, et al. Design decisions to optimize reliability of daytime cortisol
slopes in an older population. Am J Geriatr Psychiatry. 2006;14:325-33.
[261] Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical
and powerful approach to multiple testing. Journal of the Royal Statistical Society
Series B (Methodological). 1995;57.
[262] Segerstrom SC, Boggero IA, Smith GT, Sephton SE. Variability and
reliability of diurnal cortisol in younger and older adults: implications for design
decisions. Psychoneuroendocrinology. 2014;49:299-309.
[263] Hruschka DJ, Kohrt BA, Worthman CM. Estimating between- and withinindividual variation in cortisol levels using multilevel models.
Psychoneuroendocrinology. 2005;30:698-714.
[264] Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, et
al. Intensive meditation training, immune cell telomerase activity, and
psychological mediators. Psychoneuroendocrinology. 2011;36:664-81.
[265] Coteur G, Feagan B, Keininger DL, Kosinski M. Evaluation of the
meaningfulness of health-related quality of life improvements as assessed by the
SF-36 and the EQ-5D VAS in patients with active Crohn's disease. Alimentary
pharmacology & therapeutics. 2009;29:1032-41.
[266] Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R,
et al. Meditation Programs for Psychological Stress and Well-being: A Systematic
Review and Meta-analysis. JAMA internal medicine. 2014.

167
[267] Hrobjartsson A, Gotzsche PC. Is the Placebo Powerless? An analysis of
Clinical Trials Comparing Placebo with No Treatment. New England Journal of
Medicine. 2001;344:1594-620.
[268] Hasenkamp W, Wilson-Mendenhall CD, Duncan E, Barsalou LW. Mind
wandering and attention during focused meditation: a fine-grained temporal
analysis of fluctuating cognitive states. Neuroimage. 2012;59:750-60.
[269] Sood A, Jones DT. On mind wandering, attention, brain networks, and
meditation. Explore. 2013;9:136-41.
[270] Levinson DB, Stoll EL, Kindy SD, Merry HL, Davidson RJ. A mind you can
count on: validating breath counting as a behavioral measure of mindfulness.
Frontiers in psychology. 2014;5:1202.
[271] Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H,
Laskowski B, et al. Accelerate telomere erosion is associated with a declining
immune function of caregivers of Alzheimer's disease patients. Journal of
Immunology. 2007;179:4249-54.
[272] Russell E, Koren G, Rieder M, Van Uum S. Hair cortisol as a biological
marker of chronic stress: current status, future directions and unanswered
questions. Psychoneuroendocrinology. 2012;37:589-601.
[273] Wahbeh H, Kishiyama S, Zajdel D, Oken B. Salivary cortisol awakening
response in mild Alzheimer's disease, caregivers, and non-caregivers.
Alzheimer's Disease & Related Disorders. 2008;22:181-3.

168
[274] Yoshiuchi K, Yamamoto Y, Akabayashi A. Application of ecological
momentary assessment in stress-related diseases. Biopsychosocial Med.
2008;2:13.
[275] Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment.
Annual review of clinical psychology. 2008;4:1-32.
[276] Fonareva I, Amen AM, Ellingson RM, Oken BS. Differences in stressrelated ratings between research center and home environments in dementia
caregivers using ecological momentary assessment. Int Psychogeriatr.
2012;24:90-8.
[277] Sapolsky RM. Stress and the brain: individual variability and the inverted-U.
Nat Neurosci. 2015;18:1344-6.
[278] McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, et
al. Mechanisms of stress in the brain. Nat Neurosci. 2015;18:1353-63.
[279] Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview
and their use in medicine. Journal of medical systems. 2002;26:445-63.
[280] Wahbeh H, Lane JB, Goodrich E, Miller M, Oken BS. One-on-one
Mindfulness Meditation Trainings in a Research Setting. Mindfulness (N Y).
2014;5:88-99.
[281] Wahbeh H, Oken B. Objective and subjective adherence in mindfulness
meditation trials. BMC Complementary and Alternative Medicine. 2012;12 (suppl
1):P229.

169
[282] Sarason IG, Johnson JH, Siegal JM. Assessing the impact of life changes:
development of the Life Experiences Survey. J Consult Clin Psychol.
1978;46:932-46.
[283] Quinlan JR. Induction of decision trees. Machine Learning. 1986;1:81-106.
[284] Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression:
replication and exploration of differential relapse prevention effects. J Consult
Clin Psychol. 2004;72:31-40.
[285] de Vibe M, Solhaug I, Tyssen R, Friborg O, Rosenvinge JH, Sorlie T, et al.
Does Personality Moderate the Effects of Mindfulness Training for Medical and
Psychology Students? Mindfulness (N Y). 2015;6:281-9.
[286] Kligler B, McKee MD, Sackett E, Levenson H, Kenney J, Karasz A. An
integrative medicine approach to asthma: who responds? J Altern Complement
Med. 2012;18:939-45.
[287] Gawrysiak MJ, Leong SH, Grassetti SN, Wai M, Shorey RC, Baime MJ.
Dimensions of distress tolerance and the moderating effects on mindfulnessbased stress reduction. Anxiety, stress, and coping. 2015:1-9.
[288] Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, et al.
Randomized trial of yoga and exercise in multiple sclerosis: improvements in
fatigue but not cognitive function compared to control group. Neurology.
2003;60:A485.
[289] Greeson JM, Smoski MJ, Suarez EC, Brantley JG, Ekblad AG, Lynch TR,
et al. Decreased symptoms of depression after mindfulness-based stress

170
reduction: potential moderating effects of religiosity, spirituality, trait mindfulness,
sex, and age. J Altern Complement Med. 2015;21:166-74.
[290] Michalak J, Holz A, Teismann T. Rumination as a predictor of relapse in
mindfulness-based cognitive therapy for depression. Psychology and
psychotherapy. 2011;84:230-6.
[291] Carlson LE, Tamagawa R, Stephen J, Doll R, Faris P, Dirkse D, et al.
Tailoring mind-body therapies to individual needs: patients' program preference
and psychological traits as moderators of the effects of mindfulness-based
cancer recovery and supportive-expressive therapy in distressed breast cancer
survivors. Journal of the National Cancer Institute Monographs. 2014;2014:30814.
[292] Kabat-Zinn J, Chapman-Waldrop A. Compliance with an outpatient stress
reduction program: rates and predictors of program completion. J Behav Med.
1988;11:333-52.
[293] Flegal KE, Kishiyama S, Zajdel D, Haas M, Oken BS. Adherence to yoga
and exercise interventions in a 6-month clinical trial. BMC Complementary and
Alternative Medicine. 2007;7:37.
[294] Mascaro JS, Rilling JK, Negi LT, Raison CL. Pre-existing brain function
predicts subsequent practice of mindfulness and compassion meditation.
Neuroimage. 2013;69:35-42.
[295] Pace TW, Negi LT, Sivilli TI, Issa MJ, Cole SP, Adame DD, et al. Innate
immune, neuroendocrine and behavioral responses to psychosocial stress do not

171
predict subsequent compassion meditation practice time.
Psychoneuroendocrinology. 2010;35:310-5.
[296] Trottier K, Polivy J, Herman CP. Effects of resolving to change one's own
behavior: expectations vs. experience. Behavior therapy. 2009;40:164-70.
[297] Williams AL, Ness PV, Dixon J, McCorkle R. Barriers to meditation by
gender and age among cancer family caregivers. Nursing research. 2012;61:227.
[298] Freund Y, Shapiro R. A decision-theoretic generalization of on-line learning
and an application to boosting. Proceedings of the Second European Conference
on Computational Learning Theory. 1995:23-37.
[299] Khondoker M, Dobson R, Skirrow C, Simmons A, Stahl D. A comparison of
machine learning methods for classification using simulation with multiple real
data examples from mental health studies. Statistical methods in medical
research. 2013.
[300] Bishop CM. Pattern Recognition and Machine Learning: Springer; 2007.
[301] Marsland S. Machine Learning: An algorithmic approach. Boca Raton, FL:
Chapman and Hall/CRC, Taylor and Francis Group; 2009.
[302] Hariri AR, Holmes A. Finding translation in stress research. Nat Neurosci.
2015;18:1347-52.

